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CHAPTER 1. GENERAL INTRODUCTION 
INTRODUCTION
 Hen’s egg is recognized as one of nature’s most complete foods.  Eggs contain high-
quality protein and lipids as well as essential and nonessential nutrients (Huopalahti et  al., 
2007).  Basic elements in egg yolk include: sulfur (0.016%), potassium (0.112-0.360%), 
sodium (0.070-0.093%), phosphorus (0.0543-0.980%), calcium (0.121-0.262%), magnesium 
(0.032-0.128%), and iron (0.0053-0.011%) (Stadelman and Cotterill, 1995). It is also one of 
the most versatile foods. Eggs are widely used in the food industry  for their diverse 
properties including, but not limited to foaming, gelling, and emulsification (Aluko and 
Mine, 1998).  Eggs contain 70 calories per egg and have been connected with healthy eating 
habits (American Egg Board, 2011). Egg yolk protein has been tested against milk casein 
where egg protein was shown, in vitro, to be digested faster than milk casein (Sakanaka et al., 
2000). The nutrients in eggs can help with weight management, muscle strength, pregnancy 
health, brain function, eye health, and more (Weigle et al., 2005).  Diets with increased high-
quality protein, like the protein found in eggs, with a constant carbohydrate intake reduces 
the amount of energy  intake by 441 ± 63 kcal/day and a decrease in body weight by 4.9 ± 0.5 
kg over a 16-week human study (Weigle et al., 2005).  
 Eggs are made up of yolk (36%) with 50-52% of water, and the remaining is the egg 
white with 90% water (Huopalahti et  al., 2007; Aro et al., 2009). Egg yolk possess unique 
physical and chemical characteristics that can be manipulated by pH, heating, freezing, and 
drying.  Major uses of egg yolk occur in the medical, pharmaceutical, cosmetic, 
nutraceutical, and biotechnological industries (Huopalahti et al., 2007; Aro et al., 2009).  Egg 
yolk is used for food products like mayonnaise, salad dressings, baked goods, pasta, etc. 
(Aton el al., 2003).   
 Yolk lipids are primarily exist  in lipoprotein assemblies made of 62% triglycerides, 
33% phospholipids, and less than 5% cholesterol (Huopalahti et al., 2007). Fatty  acid 
composition of lipids, based on a standard feed, are as seen in Table 1.  Fatty  acid 
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composition can be altered due to modifications 
in the dietary fatty acids.  Polyunsaturated fatty 
acids (PUFA) and monounsaturated fatty acids 
(MUFA) can be more affected by  diet  yet 
saturated fatty  acids (SFA) proportions are only 
slightly affected. Triacylglycerols are typically 
esterified by palmitic acid on position 1, oleic or 
linoleic acids on position 2, and oleic, palmitic, or 
steric acids on position 3 (Huopalahti et al., 
2007).  
 Phospholipids contain one hydrophilic 
head group either consisting of phosphoric acid plus alcohol, amino acids, or polyol, and one 
hydrophobic group containing two fatty  acids (Huopalahti et al., 2007).  Phospholipids in 
eggs are primarily  phosphatidylcholine (76-80%) and phosphatidylethanolamine (11-22%) 
(Aluko and Mine, 1998; Palacios and Wang, 2005).  Of the remaining phospholipids, 
phosphatidylinositol, phosphatidylserine, sphingomyelin, cardiolipins, lysoPC, and lysoPE 
are present in low quantities.  Choline is an essential nutrient for fetal development, 
influencing brain and spinal cord structures and reducing the risk of neural tube defects 
(Zeisel, 2006).  Choline is also an important compound for neurons in the brain (Zeisel, 
2006). Cholesterol is found in the egg yolk present in low-density lipoproteins.  The 
compounds arise from feed and synthesis in the hen liver (Huopalahti et al., 2007).  
 Carotenoids concentration can range from 1.4-12.6 µg/g of yolk which give the yolk’s 
color and represent less than 1% of total yolk lipids (Surai et al., 2001; Huopalahti et al., 
2007).  Carotenoids present in the yolk include carotene, lutein, cryptoxanthin, and 
zeaxanthin (Huopalahti et al., 2007).  Lutein and zeaxanthin accumulate in the eye where the 
compounds have been suggested to reduce the risk for cataracts (up  to 20%) and age-related 
macular degeneration (up to 40%) (Moeller et al., 2000).
 Proteins are the last important group found in egg yolk.  Yolk proteins are present in 
free and apoproteins.  On a basis of dry  matter, yolk has five major protein constituents 
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Table 1. Composition of Egg Lipids 
Found Based on a Standard Feed
Fatty Acid Percentage
SFA 30-35
MUFA 40-45
PUFA 20-25
Oleic acid (18:1) 40-45
Palmitic acid (16:0) 20-25
Linoleic acid (18:2) 15-20
which are as follows: 68% low-density  lipoproteins (LDL) or also known as lipovitellins, 
16% high-density  lipoproteins (HDL), 10% globular proteins (livetins), 4% phosphoproteins 
(phosvitins), and 2% minor proteins (Huopalahti et al., 2007; Aluko and Mine, 1998; Aton et 
al., 2003; Jolivet et al., 2006).  Low density lipoproteins are the main constituent in egg yolk 
making up approximately 2/3 of the dry material made of 87% lipids and 12% proteins 
(Huopalahti et al., 2007; Aton et al., 2003).  These proteins are similar to the lipoproteins 
found in chicken blood when the blood enters the ovaries, the lipoproteins are transferred to 
the yolk (Huopalahti et al., 2007; Jolivet et al., 2006).  Described to be a polypeptide chain 
folded in a globular configuration, these proteins form spherical particles with the lipid 
molecule within the protein and a variable amount of lipid on the surface (Aluko and Mine, 
1998; Aton et al., 2003; Jolivet et al., 2006).  High-density lipoproteins are the second group, 
accounting for 1/6 of the dry yolk matter and 36% of the protein (Huopalahti et al., 2007). 
These proteins are made up of 75-80% proteins and 20-25% lipids (Huopalahti et al., 2007). 
The third group are phosphoglycoproteins called phosvitin. Of the known proteins for this 
group, 50% of the amino acids are serine and of which, 90% is phosphorylated (Huopalahti 
et al., 2007).  Due to the unique chemical characteristics, phosvitins act as phospholipid 
antioxidants (Huopalahti et al., 2007).  The last group of proteins are the globular proteins 
also known as livetins.  These proteins have different fractions including α-, β-, and γ-livetin 
at the ratio of 2:5:3, respectively.  
RATIONALE FOR NUTRIENT FEEDING PROJECT
 Egg composition can be altered by heredity genes, diet, and laying hen age 
(Frediksson et al., 2006).  Egg yolk color is attributed to the presence of β-carotene, 
zeaxanthin, crypotoxanthin, and lutein naturally found in yolks (Huopalahti et al., 2007).
 Astaxanthin (3,3’-dihydroxy-β,β-carotene-4,4’-dione) is a dark-red pigment, member 
of the carotenoid family.  Astaxanthin is the main carotenoid found in algae, such as 
Brevibaterium, Mycobacterium lacticola, Agrobacterium auratim, Haematococcus pluvialis, 
and Phaffia rhodozyma (Domínguez-Bocangegra et al., 2004). Aquatic animals including 
salmon, trout, shrimp, lobster, zooplankton, and birds, such as flamingo and quail may 
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contain astaxanthin from algae consumption directly or from the food chain (Johnson and An, 
1991).  Astaxanthin has a strong antioxidant activity, 10 times higher than β-carotene and 
more than 300 times more effective compared to α-tocopherol (Rao et al., 2009; Higuera-
Ciapara et al., 2006; Miki, 1991).  Astaxanthin from Haematococcus pluvialis is an excellent 
source not only for pigmentation, but also for protection against lipid oxidation, UV 
photoxidation, inflammation, cardiovascular disease, cellular health, and cancer (Guerin et 
al., 2003).
 Tocotrienols and tocopherols are fat-soluble vitamins and generically  named as 
vitamin E, whose antioxidant properties are well studied.  Within the vitamin E analogs, α-
tocopherol is considered the most active form (Theriault et al., 1999).  Bioavailability of 
vitamin E is greatly influenced by food matrix, formulation, and food processing (Reboul et 
al., 2006).  Vitamin E is thought to prevent atherosclerosis (Stephens et al., 1996), protect 
against coronary  disease (Stampfer et al., 1993), oxidative stress, development of 
Alzheimer’s disease (Li et al., 2001), reduce bone loss, have immunomodulatory functions, 
gastroprotective effects, anti-aging, and skin protective effects (Aggarwal et al., 2010).
 Previous work on astaxanthin has shown successful pigmentation to egg yolks, 
salmon, trout, and chicken meat.  A study by  Akiba et al. (2000) examined the effects of 
feeding a red yeast, Phaffia rhodozyma, that contained astaxanthin to increase the color of 
egg yolk.  The authors used very low concentrations of astaxanthin, 0, 2, 4, 8, and 16 ppm for 
four weeks to feed hens. The yolk color score was increased from 6.6 (golden yellow) to 12.7 
(orange) on the Roche color fan.  Dike et al. (1992) completed a similar study using laying 
hens with 0.3% Phaffia rhodozyma, broken or intact yeast  cells for eight months to increase 
the Roche color fan score by  only 1 point (intact cells) and 2 points (broken cells) taking the 
color from a yellow to a more golden yellow.  Johnson et  al. (1980) used the same yeast, 
Phaffia rhodozyma, for laying hens and Japanese quail, and examined the various 
concentrations of astaxanthin in the diet. They also examined the effect of intact red yeast 
cells, mechanically fractured, and oil extracted from the yeast on individual chickens.  The 
astaxanthin from the fractured cells and oil was deposited in the yolk.  Another study by 
Nelson and Baptist (1967) fed quail astaxanthin with or without lutein.  Results concluded 
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less total pigment was needed when astaxanthin and lutein were combined than with lutein 
alone.  The authors also examined the effects of astaxanthin pigment in yellow and white 
corn diets.  Astaxanthin in white corn was more effective with yolk pigmentation than in 
yellow corn diet due to the other naturally occurring carotenoids.  Lastly, a study completed 
by Takahashi et al. (2004) evaluated the effect of astaxanthin feed containing 0, 50, or 100 
mg/kg of astaxanthin from Phaffia rhodozyma over two weeks on broilers. From tissues 
examined for astaxanthin concentration, the highest concentration resulted in the small 
intestine followed by subcutaneous fat, abdominal fat, spleen, liver, heart, kidneys, and skin. 
The lowest astaxanthin concentration resided in the muscle.  Despite the low levels in the 
muscle, Takahashi et al. (2004) were able to show that astaxanthin was transported to 
different tissues.  All of these studies demonstrated successful incorporation of astaxanthin in 
a variety of tissues, from eggs to muscle tissues and plasma levels.
 Astaxanthin has also been used to pigment other tissues besides egg yolks.  One study  
by Gobantes et al. (1998) used 5% astaxanthin in the diet to feed rainbow trout 
(Oncorhynchus mykiss) to examine the color stability in vacuum packaging over storage 
time.  This study found considerable color variations among the neck, tail, and back parts 
along the fish but failed to maintain the color stability  over 15-day storage time.  Another fish 
pigmentation study completed by Barbosa et al. (1999), evaluated the blood of rainbow trout 
(Oncorhynchus mykiss) by feeding the fish two different sources of astaxanthin, green algae 
Haematococcus pluvialis and commercial beadlets of 8% astaxanthin.  Four diets were used, 
two of which with the astaxanthin from algae, 129.8 and 142.0 mg/kg of feed dry matter, and 
two from the synthetic source, 110.1 and 119.7 mg/kg of feed dry matter.    They were able to 
astaxanthin achieve serum levels from 5.3 to 9.0 µg/ml.  Higher levels in the serum were 
achieved with high lipid levels in the diet  independent of astaxanthin source.  Johnson et al. 
(1977) used Phaffia rhodozyma as a dietary supplement, 15% wt/wt, for salmonoids and 
crustaceans.  They used lobster feed either at two different yeast concentrations, or a diet of 
brine shrimp that contained astaxanthin.  The results showed the lobsters fed the yeast diets 
did not grow or accumulate as much astaxanthin as the lobsters fed the shrimp.  Also within 
this study, the authors examined rainbow trout fed yeast diets that also increased tissue 
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pigmentation.  However, there is little research completed to incorporate astaxanthin at 
concentrations where health benefits can be reached. The study in chapter 3 will try to 
answer the dose in feed versus the concentration in egg yolk relationship.
 Vitamin E transfer analysis from supplemented feed to hen eggs is another topic for 
this study.  Sen et al. (2006) noted for all the vitamin E papers in PubMed there is less than 
1% related to tocotrienols. There have been several feeding studies dealing with vitamin E 
enriched feed for the nutrient to transfer to eggs.  One study by  Flachowsky et al. (2002) 
examined the effect of vitamin E supplementation on α-tocopherol concentration on foods of 
poultry  origin.  This study fed 0, 100, 1000, 10,000, and 20,000 mg vitamin E/kg of feed. 
Eggs had the highest levels of α-tocopherol.  Another study by Franchini et al. (2002) used 
DL-α-tocopheryl acetate, 100 or 200 mg/kg of feed, and ascorbic acid, 500 or 1000 mg /kg of 
feed to increase levels in eggs, and were successfully incorporated α-tocopherol into eggs. 
Galobart et  al. (2001) added 0, 50, 100, and 200 mg/kg α-tocopheryl acetate to a base diet 
containing 5% linseed oil to determine the amount transferred to eggs.  They  were able to 
achieve a dose-dependent manner with a range of 16-132 µg/g in egg.  The last example is by 
Grobas et  al. (2002) added α-tocopheryl acetate and vitamin A to the diet to assess the 
supplementation levels in the egg yolk.  Kang et al. (1998) used palm oil, 1.5% or 3.5%, to 
increase the α- and γ-tocotrienol content in eggs, liver, meat, and adipose tissues of hens. 
They  showed that α-tocopherol was the major tocopherol isomer in egg lipid, and increasing 
α-tocotrienol from 1.1 µg/g in control diet to 10.8 µg/g (in the 1.5% palm oil diet) and 6.2 
µg/g (in the 3.5% palm oil diet) and  γ-tocotrienol from 2.4 µg/g in control diet to 5.2 µg/g 
(in the 1.5% palm oil diet) and 4.7 µg/g (in the 3.5% palm oil diet).  Concentrations of α- and 
γ-tocotrienol in the liver, white meat, dark meat, and adipose tissues were generally higher in 
the increased diets with palm tocotrienols and tocopherols (tocos) but not always significant 
from the control diet (Kang et al., 1998).
 Tocotrienols should not be avoided for feed enhancement studies as these compounds 
possess powerful neuroprotective, anticancer, and cholesterol lowering properties that are not 
often shown by tocopherols. A study by Osakada et al. (2004) used palm oil to investigate the 
effects of vitamin E on oxidative stress and apoptosis using primary neuronal cultures from 
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rat striatum.  Each of the different analogs were purified from the palm oil and examined.  All 
the tocotrienols significantly decreased hydrogen peroxide induced neurotoxicity, but α-
tocopherol did not. α-, γ-, and δ-Tocotrienols had protection against cytotoxicity of 
superoxide donors, paraquat, and nitric oxide donors.  
 Another study evaluated γ-tocotrienol antitumor activity on human hepatoma Hep3B 
cells (Sakai et al., 2006) and found low levels of γ-tocotrienol and shorter treatment  was able 
to inhibit cell proliferation better than α-tocotrienol. Lastly, a study completed by Lee et al. 
(2009) examined the effect on exercise endurance and oxidative stress on forced swimming 
rats that were fed tocotrienol-rich or D-α-tocopherol rich diets.  They  concluded the 
tocotrienol was able to improve the physiological condition and reduce exercise-induced 
oxidative stress in rats. Tocotrienols have specifically been linked for neuroprotection, 
cholesterol, blood pressure lowering, anti-aging, antioxidant, anticancer, anti-angiogenic, 
anti-inflammatory, immune function, improving obesity, osteoporosis, eye, and bone health 
(Sen et  al., 2006). Sen et al. (2006) has a comprehensive list of the studies dealing with these 
health issues. Because of many health benefits of tocotrienols, these compounds should be 
examined for their transfer to a widely  used food product, this is where the current study can 
fill the literature gap.
RATIONALE FOR ARTIFICIAL OIL BODY RESEARCH
 Lipid oxidation and secondary oxidation product generation have been a serious 
concern for food industry relating to food quality  and consumer health.  One factor 
influencing lipid oxidation is the degree of unsaturation. Several studies illustrate linoleic 
acid oxidation was 20-40 times faster than oleic acid (Kolakowska, 2003; Frankel, 1980; 
Fatemi and Hammond, 1980).  Polyunsaturated fatty  acids are a significant amount of total 
lipid due to the natural occurrence and presence in fortified formulations and more prone to 
oxidation than other lipids.  Another factor that can influence the rate of oxidation is 
transition metal ions, copper and iron, which are commonly found in food emulsions (Wang 
and Wang, 2008).  Copper is less likely to be found in food but has been shown to be more 
active accelerating primary oxidation product decomposition (Yoshida and Niki, 1992). 
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Other factors, such as oxygen availability, storage temperature, and pH can also affect 
oxidation rate.  
 Naturally occurring oil bodies protect lipids from oxidation and can be utilized by 
food manufactures for the same purpose.  Artificial oil bodies can serve similar purposes, 
such as carriers for hydrophobic molecules like nutraceutical compounds, pharmaceutical 
drugs, probiotics, or healthy fatty acids (Chen et  al., 2004; Peng et  al., 2003; Chiang, 2010). 
Plant oil bodies are very  stable at neutral pH values.  They do not aggregate or coalesce in 
vivo during seed maturation or after centrifugation (Haung, 1994).  Oil bodies consist of three 
basic components, proteins, phospholipids, and triglycerides (Huang, 1992). They have a 
matrix composed of triacylglycerols covered by  a phospholipid monolayer with unique 
proteins, such as oleosins, caleosins, and steroleosins (Bhatla et al., 2010; Frandsen et al., 
2001; Huang, 1994). Oil bodies have been observed from mature seeds of rape (Brassica 
napus L.), mustard (Brassica juncea L.), cotton (Gossypium hirsutum L.), flax (Linus usitatis 
simum), maize (Zea mays L.), peanut (Arachis hypogaea L.), and sesame (Sesamum indicum 
L.) (Tzen et al., 1993).  Plants use the oleosomes as energy  sources for germination and post-
germinative seedling growth (Tzen et al., 1998; Peng et al., 2003). Oleosomes are held 
together by simple physical forces, steric hindrance and negative surface charge by oleosin 
(Huang, 1992; Chiang, 2010).  Oleosomes are stable both in vitro and in vivo (Chiang, 2010).
 Hen egg yolk is typically marketed whole providing low added value (Anton and 
Gandemer, 1997) despite the range of various functional properties and composition.  The 
proteins in egg yolk typically are hydrophilic, but also contain hydrophobic groups that can 
be absorbed into oil-water interface (Daimer and Kulozik, 2010).  Egg yolk consists of a 
mixture of proteins with wide ranges of molecular weights, pI, and roles in emulsions 
(Daimer and Kulozik, 2010).  Egg yolk proteins can provide stabilizing effects in food 
systems with low pH (Nilsson et al., 2007).  For this study, egg lecithin was used since it 
contains less linoleic, almost no linolenic acid, and more long-chain polyunsaturated fatty 
acids as compared to soy lecithin (Wang and Wang, 2008).  
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 With the ease of PUFAs oxidation, it is the goal of this study to create artificial oil 
bodies with egg yolk protein to mimic naturally occurring oleosomes to protect oil from 
oxidation.
THESIS ORGANIZATION
 The contents of this thesis include a general introduction, literature review for both 
studies, manuscripts prepared for journal submissions for both studies, and general 
conclusion chapter.
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CHAPTER 2. LITERATURE REVIEW-NUTRIENT FEEDING STUDY
GENERAL INTRODUCTION
 Carotenoids are naturally  found in egg yolk which give its yellow color.  The color 
can range from a pale yellow to a dark orange.  Color plays as a quality  criterion thus 
carotenoid content is an important to egg quality because good yolk color is desirable 
(Huopalahti el al., 2007).  Typically, the carotenoids found in egg yolk are from the 
xanthophyll family.  Lutein, cryptoxanthin, and zeaxanthin are found in the yolk with the 
concentration of lutein and zeaxanthin combined are ten times greater than cryptoxanthin 
(Huopalahti et al., 2007).  Carotene is the main carotenoid commonly found in corn-based 
feed.  After ingestion of the feed, carotene is converted to the oxidized form of xanthophylls 
(Huopalahti et al., 2007).
 Astaxanthin (3,3’-dihydroxy-β,β-carotene-4,4’-dione) is a dark-red pigment and a 
member of the carotenoid family.  The source of astaxanthin for this study was from algae, 
Haematococcus pluvialis, astaxanthin dry mass concentration of 1.35% (Cyanotech Spec 
Sheet, 2010).  Astaxanthin is used in industry as a feed pigment for poultry, trout, salmon, 
and shrimp (Bolin et  al., 2010).  Specifically in salmonids, astaxanthin is used over 
canthaxanthin because astaxanthin pigmentation is more nature-identical and more efficiently 
deposited in the tissues (Barbosa et al., 1999).  Other applications have been growing in the 
medical field showing potential use as an antioxidant, photoprotectant, cardiovascular disease 
preventer, and immune booster.  Astaxanthin has been shown in vitro studies to have 
antioxidant properties up to 500 times of other commercial carotenoids like vitamin E.  This 
carotenoid’s structure is related to β-carotene, zeaxanthin, cryptoxanthin, and lutein.    
 Tocotrienols and tocopherols are fat-soluble vitamins and generically  named as 
vitamin E.  Their antioxidant properties have been well studied.  Within the vitamin E group, 
α-tocopherol is considered the most active form, reverses vitamin E deficiency symptoms, 
and is the most abundant form in nature (Theriault et  al., 1999; Brigelius-Flohé and Traber, 
1999).  Bioavailability of vitamin E is greatly  influenced by food matrix, formulation, and 
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food processing (Reboul et al., 2006).  Vitamin E food sources include sunflower seeds, 
almond, and hazelnuts (Reboul et al., 2006).  Tocopherols are present in corn, wheat, and 
soybeans while tocotrienols are present in barley, oats, palm, and rice bran (Aggarwal et al., 
2010). Vitamin E cannot be synthesized in the human body, therefore must be obtained from 
the diet (FDA: GRAS 307).  Vitamin E has been known to be an essential nutrient since 1922 
(Brigelius-Flohé and Traber, 1999).
 This review will focus on astaxanthin, tocopherols, tocotrienols, their health benefits, 
safety of these compounds, bioavailability, and digestibility.
ASTAXANTHIN
 Astaxanthin (3,3’-dihydroxy-β,β-carotene-4,4’-dione) is a dark-red pigment, member 
of the carotenoid family, and the main carotenoid found in algae and aquatic animals 
including salmon, trout, shrimp, lobster, zooplankton, and birds, such as flamingo and quail 
(Johnson and An, 1991).  Although most of these 
animals cannot synthesize it  de novo from other 
carotenoids, they  can obtain it from natural 
sources of astaxanthin.  Natural sources of the 
pigment are also from bacteria such as 
Brevibaterium, Mycobacterium lacticola, 
Agrobacterium auratim, Haematococcus 
pluvialis, and Phaffia rhodozyma (Domínguez-
Bocanegra et al., 2004).  Astaxanthin is used for 
pigmentation and feed additive for poultry, 
salmon, trout, and shrimp (Higuera-Ciapara et al., 
2006).  The pink or red pigmentation is a direct 
result of astaxanthin consumption (Holtin et al., 
2009).  The pigment is commercially produced by 
Haematococcus pluvialis, a microalgae where the 
pigment can accumulate between 0.2-4% dry 
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Table 1. Composition of Astaxanthin 
Components Composition (%)
Natural Astaxanthin
Total Fat
Protein
Carbohydrates
Dietary Fibers
Moisture
Ash
Free Astaxanthin
Monoester
Diester
Di-cis-astaxanthin
Trans-astaxanthin
9-cis astaxanthin
13-cis astaxanthin
15-cis astaxanthin
1.35
20-25
20-35
30-55
18
<9
<17
1.9
84.25
13.85
2.22
74.07
6.66
8.15
0.74
 Adapted from ALGAtechnologies (1998) spec 
sheet,  Cyanotech certificate of analysis (2010) 
and Cyanotech analysis report (2011).
weight basis (Steinbrenner and Linden, 2003; Johnson and An, 1991). Haematococcus 
pluvialis is a member of the family Chlorophyceae and is known to accumulate carotenoids 
under stress conditions (Rao et al., 2009).  This study used BioAstin, a dry flake/powder of 
natural astaxanthin, from Cyanotech Corporation in Hawaii.  Natural astaxanthin exists in 
free (alcohol) form, but  primarily as a monoester, and diester.  The BioAstin composition is 
reported in Table 1.
 Structure of Astaxanthin. Typical carotenoids are 40 carbon atoms hydrocarbons 
with two terminal rings joined by a chain of conjugated double bonds. Xanthophylls are 
oxygenated derivatives (Higuera-Ciapara et al., 2006).  Due to the conjugated chain, each 
double bond can exist in two geometric configurations, cis or trans.  Cis-isomers are 
thermodynamically less stable than the trans isomer.  Because of the isomer stability most 
carotenoids found in nature predominantly exist in the all-trans isomer (Higuera-Ciapara et 
al., 2006).  Astaxanthin incorporates oxygen as OH group and as oxi-groups.  It  exists in five 
stereoisomers but mostly in the 3S, 3’S conformation in Haematococcus pluvialis (Misawa et 
al., 1995; Holtin et al., 2009).  The stereoisomers are shown in Figure 1.  Unique features of 
astaxanthin are the hydroxyl and keto endings of each ring explaining the ability to be 
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Figure 1. Astaxanthin stereoisomers of the three all-trans (3S 3’S, 3R 3’R, and 3S 3’R) and the 
two cis isomers (9-cis and 13-cis).  Figure adapted from Holtin et al., 2009.
esterified, the high antioxidant activity, and more polar characteristics than other carotenoids. 
Astaxanthin in the all-trans formation is unstable and readily transforms to the cis 
conformation by heat, light, or 
metal ions (Holtin et al., 2009).  
 Haematococcus pluvialis 
Life Cycle.  The astaxanthin for this 
s t u d y i s f r o m f r e s h w a t e r 
m i c r o a l g a e , H a e m a t o c o c c u s 
pluvialis, a unicellular alga from the 
class Chlorophyceae (Goodwin and 
Jamikorn, 1953).  The microalgae 
has a 2-week life cycle consisting of 
four stages: vegetative cell growth, 
encystment, maturation, and germination (Figure 2) (Kobayashi et al., 1997).  Each stage is 
uniquely recognized by the ratio of carotenoid/chlorophyll and the intracellular protein 
content (Kobayashi et  al., 1997).  The first stage, vegetative cell growth, cells exists as 
ellipsoidal in shape ranging in size for 8 to 50 µm (Boussiba, 2000) in diameter and is 
capable of swimming with two equal length flagella with a characteristic green color 
(Kobayashi et al., 1997).  The flagella emerge at a wide angle from the anterior papilla where 
the cell wall is greatly  thickened.  The cellular structure consists of a cup-shaped chloroplast 
with numerous scattered pyrenoids and contractile irregular vacuoles near the cell wall 
(Boussiba, 2000).  There are high levels of chlorophyll and protein present but low levels of 
carotenoids (Kobayashi et al., 1997). The cellular structure remains the same during the 
mobile stage (Boussiba, 2000). 
 At the second stage the cells become spherical, immotile cysts form, called the 
‘palmella’ stage (Kobayashi et al., 1997; Boussiba, 2000).  Once growing conditions become 
less favorable, cells increase their volume, entering a resting stage, develop a heavy  and 
resistant cellulose wall made from sporopoline-like substances, and become brown in color 
(Boussiba, 2000).  Degradation of chlorophyll and protein occurs also during the encystment 
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Figure 2. Life cycle schematic of Haematococcus pluvialis.
stage.  During maturation, carotenoid biosynthesis significantly  increases as does protein 
degradation (Kobayashi et  al., 1997).  This stage is easily  recognized as the protoplast takes 
on a more characteristic red color due to the increase of astaxanthin (Boussiba, 2000; 
Goodwin and Jamikorn, 1954; Harker et  al., 1996).  Peak cellular astaxanthin concentration 
is achieved after 78 hours of high light stress (Kim et al., 2006).  Astaxanthin is thought to be 
a photoprotectant reducing the amount of light to light-harvesting pigment protein complexes 
thus reducing the risk of photo-inhibition (Harker et al., 1996).  Astaxanthin may also 
provide a physiochemical protective barrier preventing free-radical damage within the cell 
(Harker et al., 1996).  During the increased astaxanthin concentration stage, there are a 
number of proteins that are induced in the red cyst cells compared to the green vegetative 
cells (Kim et al., 2006).  Two of the important proteins are isopentenyl pyrophosphate 
isomerase and lycopene β-cyclase appear to be involved with carotenoid accumulation within 
the cytoplasm (Kim et al., 2006).  
 After the maturation stage, intracellular daughter cells are released from the mature 
cyst cell during germination (Kobayashi et al., 1997).  Chlorophyll and protein synthesis 
occur while carotenoid degrades.  The daughter cells then grow mixotrophically  into the 
vegetative cell stage (Kobayashi et al., 1997).  
 Carotenogenesis in Haematococcus pluvialis. In organisms with photosynthetic 
electron transport chain there is an unavoidable consequence for the production of reactive 
oxygen species (ROS).  Chloroplasts are a rich source of ROS because of the abundant 
oxygen supply and highly  energetic reactions forming ATP and NADPH.  When 
environmental conditions become more stressful, ROS will be produced when energy 
balance between absorption of solar energy and CO2 fixation is quenched (Boussiba, 2000). 
Excessive irradiance can cause the generation of triplet chlorophyll that can form 1O2 
(Boussiba, 2000).  This reaction can continue as long as the triplet  chlorophyll has not been 
quenched by carotenoids.  Kobayashi et al. (1993) have shown ROS and 1O2 may have some 
involvement with astaxanthin accumulation.  Light is not necessary for the production of 
astaxanthin as shown by  Droop (1955).  Other environment stresses that cause 
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carotenogenesis in Haematococcus pluvialis are mineral deprivation, salt stress, excess light, 
low temperatures, drought, and aging.
 Carotenoid pigments are synthesized in the chloroplasts of algae.  In Haematococcus 
pluvialis contains a set of enzymes responsible for the conversion of β-carotene to 
canthaxanthin to astaxanthin.  The specific steps of astaxanthin biosynthesis in 
Haematococcus pluvialis as seen in Figure 3 are carried out by two enzymes, β-carotene 
ketolase (BKT) and carotenoid hydroxylase (CHY) (Steinbrenner, 2003).  Formation of 
astaxanthin takes place by the initial formation of canthanxanthin with the precursor being β-
carotene.  Unique to Haematococcus pluvialis, unlike other photosynthetic organisms, the 
accumulation of β-carotene and derived xanthophylls reside in the chloroplast, astaxanthin is 
found in the cytosol.  Enzyme activities specific to astaxanthin biosynthesis occur in the 
cytoplasm whereas the enzymes required for general carotenoid pathway are located in the 
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 Figure 3. Biosynthetic pathway of astaxanthin in Haematococcus pluvialis.   The enzymes in 
the pathway are β-carotene ketolase (BKT) and carotenoid hydroxylase (CHY) (Steinbrenner, 
2003).
chloroplast (Steinbrenner, 2003).  Unique to Haematococcus pluvialis astaxanthin exists in 
three different forms that  can be classified as free (~5%), monoesters (~70%), and diesters 
(~25%) (Kamath et al., 2008).  The different forms can be seen in Figure 4. Typical fatty 
acids attached in the esterified form are C18:3, C18:2, C18:1, and C16:0 (Hotin et al., 2009).
 Mechanism of Antioxidation.  Astaxanthin acts as a quencher of singlet  oxygen and 
other free radicals by absorbing the excited energy onto the polyene electron-rich chain thus 
preventing cellular components from damage.  This absorption results in an excitation of the 
carotenoid to a triplet state.  Dissipation of the extra energy is given off by heat thus 
returning the compound to ground state (Algatech, 2004).  Results from Miki (1991) 
illustrate the number of carbonyl and hydroxyl groups in the carotenoids that are important 
for quenching activities.  Astaxanthin is most likely to reside in the phospholipid bilayer so 
the polar OH-groups in the rings are near the membrane surface and the polyene chain in the 
interior (Goto et  al., 2001).  With this orientation the heads of the molecule can scavenge 
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 Figure 4.  Structure of astaxanthin in the free, monoester, and diester form.  R can be saturated or 
unsaturated acyl chain.  Figure adopted from Kamath et al., 2008.
reactive oxygen species at or near the surface and the polyene chain can inhibit radical chain 
reactions inside the membrane (Goto et  al., 2001).  Potential intermolecular hydrogen bonds 
can be formed between the polar ends of astaxanthin and the polar groups of the surrounding 
phospholipids (Goto et  al., 2001). Another possible way for astaxanthin to bond with the 
surrounding phospholipids is by the hydroxyl and carbonyl groups of astaxanthin readily 
forming intramolecular hydrogen-bonded five-membered ring, therefore increasing the 
hydrophobicity allowing for further advantages within the bilayer, like stabilizing the carbene 
radicals (Goto et al., 2010).  Goto et al. (2001) also suggested the C3 methine is the radical 
scavenging site of the terminal ring. The radical scavenging ability of the terminal ring is not 
likely to be affected by  the methyl groups and polyene change, therefore the rings and chain 
radical scavenging activity  are independent  of each other (Goto et al., 2001).  The terminal 
ring has the unique property  to scavenge radicals both on the surface and in the interior of the 
membrane while their chain can only scavenge inside the membrane (Goto et al., 2001).
HEALTH BENEFITS OF ASTAXANTHIN
 Astaxanthin as an Antioxidant.  Free radicals like hydroxyl and peroxyl radicals are 
highly  reactive forms of oxygen and are produced by  the body  during normal metabolic 
reactions and processes.  Physiological stress, exposure to chemicals or ultraviolet light, air 
pollution, or tobacco smoke, can magnify the production of free radicals.  Free radicals can 
do damage to DNA, proteins, and lipid membranes in vivo. All the constant bombardment 
leads to oxidative stress.  Antioxidants such as carotenoids may help  to prevent harm by 
absorbing the energy  of the singlet  oxygen into the carotenoid molecule avoiding damage of 
surrounding tissues or cellular components (Guerin et al., 2003; Goto et al., 2001). 
 Astaxanthin is an effective protecting compound for membrane phospholipids and 
other lipids against peroxidation.  Astaxanthin has a strong antioxidant activity, 10 times 
higher than β-carotene and more than 300 times more effective to α-tocopherol (Rao et al., 
2009; Higuera-Ciapara et al., 2006; Miki, 1991). Astaxanthin is also more effective in 
scavenging hydroxyl radicals than β-carotene (Karppi et al., 2007).  Astaxanthin is able to 
reduce the endogenous oxidative stress level.  Wolf et al. (2010) suggest astaxanthin does not 
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directly  scavenge reactive oxygen species like superoxides or peroxides.  Astaxanthin is 
extremely lipophilic thereby unable to cross membranes so it protects cells against oxidative 
damage in the membrane (Wolf et al. 2010).  A study completed by Bolin et al. (2010) 
suggests astaxanthin displays anti-inflammatory effects by  preserving redox-sensitive and 
essential structures of human lymphocytes in vitro.  There was data that also suggest the 
astaxanthin dosage level (5 µM) hindered lymphocyte proliferation by the increase in nitric 
oxide formation, but it would be improbable to achieve such high levels of astaxanthin in 
vivo. This and other studies also suggest  astaxanthin has the capacity to scavenge reactive 
oxygen species in vivo (Bolin et al., 2010; Rao et al., 2009; Kamath et al., 2008).  The 
antioxidant scavenging activity with IC50 of ~8 µg/mL and reducing power of 59*103 U/g in 
vitro (Kamath et al., 2008).
 A study completed by Kim et al. (2009) examined astaxanthin efficacy  against high-
glucose-induced oxidative stress, inflammation and apoptosis in proximal tubular epithelial 
cells by assessing lipid peroxidation, total reactive species, superoxide, nitric oxide, 
peroxynitrite, and inflammatory proteins.  Results of this study showed astaxanthin had a 
protective property in reducing oxidative stress, inflammation, and apoptosis caused by high 
glucose exposure for these cells.
 Astaxanthin as a Photoprotectant.  Photons coming from the sun are constantly 
bombarding earth with 56% being infrared light (780-5000 nm), 39% visible light (400-780 
nm) and 5% UV light (González et al., 2008).   Exposure to light, especially ultraviolet A 
(320-400 nm) and ultraviolet B (290-320 nm), can lead to production of free radicals and 
photo-oxidative damage to lipids and tissues (Lee et al., 2000).  Carotenoids have an 
important role in protecting these tissues against UV-light photo-oxidation and they are 
usually  found in tissues directly  exposed to sunlight, like the skin (Lee et al., 2000; O’Connor 
and O’Brien, 1998).  Astaxanthin particularly is efficient at eliminating peroxilipidic radicals 
and inhibiting the concentration of free polyamines and protecting fibroblasts from photo-
induced damage (González el al., 2008).
 A study by Kobayashi et al. (2000) examined the protective role of astaxanthin 
against UV in Haematococcus pluvialis.  Astaxanthin-rich mature cyst cells were six folds 
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more tolerant to UVB and three folds more tolerant to UVA than immature cysts.  Kobayashi 
el al. (2000) concluded there is evidence for astaxanthin to protect against UV light.
 O’Connor and O’Brien (1998) assessed the ability of β-carotene, lutein, and 
astaxanthin in protecting against UVA-induced oxidative stress in rat kidney  fibroblasts. 
Tissue cells were exposed to UVA light  (320-400 nm) at a dose of 5.6 mW/cm2.  Results 
illustrated that a much lower concentration of astaxanthin (10 nM) compared to β-carotene (1 
µM) and lutein (1 µM) was required to decrease superoxide dismutase and catalase activities. 
This study concluded astaxanthin protects against UVA light-induced oxidative stress in vitro.
 Another study  by Camera et al. (2008) used human dermal fibroblasts in the presence 
of astaxanthin, canthaxanthin, or β-carotene for 24 hours prior to UVA exposure.  There was 
a higher uptake of astaxanthin by the fibroblasts compared to the other compounds. 
Astaxanthin was determined to protect  against UVA-induced alterations to a significant level. 
The authors concluded astaxanthin has a superior preventive effect against changes from 
photo-oxidation in cell culture.
 Astaxanthin and Cardiovascular Disease (CVD).  Oxidative stress and inflammation 
play  important roles in the different aspects of CVD, including endothelial dysfunction, 
functional lipid disorders, periprocedural myocardial damage, and atrial fibrillation. Triggers 
like hypertension, dyslipidemia, diabetes, and obesity  increase oxidative stress.   Astaxanthin 
reduces LDL oxidation in humans in contrast to other antioxidants (Pashkow et al., 2008). 
Studies have shown significant  reductions in oxidative stress, hyperlipidemia, and 
inflammatory markers of cardiovascular disease by oral supplementation of astaxanthin in 
animal case studies.  There were few studies investigating the potential benefits of 
astaxanthin and CVD on humans except an ongoing study  (Fassett et al., 2008) involves 66 
renal transplant recipients investigating the effect of oral astaxanthin supplementation of 12 
mg/day for one year on arterial stiffness, oxidative stress, and inflammation.  The results of 
this study may lead to a larger intervention trial to assess cardiovascular morbidity and 
mortality (Fasset et al., 2008).
 Anticancer Properties of Astaxanthin.  Colon cancer is one of the major causes of 
mortality worldwide.  Colonic crypt cell hyperproliferation has been suggested to play  a 
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significant role in the formation and development of this type of cancer (Prabhu et  al., 2009). 
ROS plays a role in the various stages of colon carcinogenesis and tumorigenesis.  With 
carotenoid’s antioxidant properties, they have a chemopreventive agents (Prabhu et al., 
2009). The study  by  Prabhu et al. (2009) concluded that astaxanthin administered to rats 
orally at  a concentration of 15 mg/kg body weight suppressed the total number of aberrant 
crypt foci and the development of multi crypt foci.  
 A study by Tanaka et al. (1994) tested the effects of astaxanthin (50 ppm) on mice 
given N-butylN(4-hydroxybutyl) bitrosamine, a urinary bladder carcinogen, for 20 weeks. 
The mice who were given the astaxanthin had smaller preneoplastic lesions in their bladder 
and a significantly reduced incidence of bladder cancer than the control group.  The authors 
concluded astaxanthin is a possible chemopreventive agent for bladder carcinogenesis by 
suppressing cell proliferation.
 Astaxanthin has also been associated with relieving other types of diseases or 
conditions such as: age-related macular degeneration, Alzheimer’s and Parkinson’s diseases, 
high cholesterol, inflammatory diseases, dyspepsia, muscle function, anti-hypertension, stress 
management, and repair of damage caused by  lack of oxygen from a stroke (Lorenz and 
Cysewski, 2000; Guerin et al., 2003).  This review of astaxanthin’s health benefits is only a 
small portion of the potential this compound has to offer.
SAFETY CONCERNS WITH ASTAXANTHIN
 The FDA in 1987 conducted safety and toxicology studies on astaxanthin.  Acute and 
subacute (10-day) toxicology study in rats (up to 1.2 g/kg/day for 91 days) and in dogs (up  to 
162 mg/kg/day for 91 days) demonstrated minor effects in rats and no effects in dogs at the 
highest dose.  Reproductive toxicology  was evaluated in rats and rabbits with no effects from 
the doses up to 1 g/kg/day.  Since the FDA’s approval, astaxanthin has been used as a feed 
additive primarily for salmon.  Other published human clinical trials using astaxanthin have 
also proven the safety of the carotenoid (Pashkow et al., 2008).  Astaxanthin supplements 
have been available commercially  since 2000.  Comparisons with 62 over-the-counter drugs 
including aspirin or ibuprofen, astaxanthin was reported to be as effective or more effective 
25
in 76% of the comparisons for relieving sore muscles, back pain, rheumatoid arthritis, and 
macular degeneration etc. (Guerin et  al., 2003).  However, the high effectiveness must be 
taken with caution, as placebo effects cannot be ruled out (Guerin et al., 2003).  In 2010 
FDA accepted Haematococcus pluvialis extract containing astaxanthin esters to be on the 
Generally Recognized As Safe (GRAS) list (GRAS 294, 2011).
 A study by Mera Pharmaceuticals (1999) used 33 adult volunteers whom were given 
natural astaxanthin over 29 days where participants were given 3.85 mg or 19.25 mg of 
astaxanthin a day (Guerin, 2003).  From the study, no ill effects or toxicity  was found from 
the astaxanthin supplement (Guerin, 2003).
 Spiller and Dewell (2003) used 35 healthy  adults ranging in age from 35-69 years in a 
randomized, double-blind, placebo-controlled trial for 8 weeks.  Participants were given three 
gelcaps per day to be taken with meals.  Each gelcap contained 2 mg of astaxanthin in 
safflower oil for the treatment group and the placebo had safflower oil only gelcaps.  Blood 
pressure, blood chemistry test including comprehensive metabolic panel and blood cell count 
were analyzed at the beginning, after four weeks, and after eight weeks during the study. 
Only slight differences were found, yet the differences did not have any  clinical importance. 
The researchers concluded 6 mg of astaxanthin from Haematococcus pluvialis per day can be 
consumed safely by healthy adults (Spiller and Dewell, 2003).
HUMAN BIOAVAILABILITY OF ASTAXANTHIN
 Bioavailability of lipophilic carotenoids varies from 10% in raw uncooked vegetables 
to 50% in oily solutions or synthetic commercial formulations (Odeberg et al., 2003).  This 
difference in bioavailability can be explained by incomplete release from food matrices or by 
the dissolution limitations of the gastrointestinal fluids (Odeberg et al., 2003).  Another 
possible explanation is the limits of absorption (Parker, 1996).  Astaxanthin, like other 
xanthophylls, are typically  present in esterified forms, mono and diesters, and must be 
hydrolyzed before absorption (Zaripheh and Erdman, 2002).  Dissolution from the food 
matrix and incorporation into micelles are two important steps before absorption across the 
membrane.  Once the xanthophylls have been absorbed by the mucosal cells they are 
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incorporated into chylomicrons (Zaripheh and Erdman, 2002).  The xanthophylls that are not 
incorporated into chylomicrons are thought to be returned to the intestinal lumen (Zaripheh 
and Erdman, 2002).  
 A study  by Odeberg et al. (2003) used 32 healthy male subjects with age range of 
20-46 and were given three different treatments of lipid based gelatin capsules. All three 
treatments enhanced the bioavailability of astaxanthin by 1.7 to 3.7 fold.  Another study by 
Okada et al. (2009) examined bioavailability  and timing of either after or before eating a 
meal and the effects of smoking habits.  This study involved 15 males (age 18-60) and 5 
females (26-32) with the a single dose of 40 mg.  Some subjects were given the astaxanthin 
either 2 hours before or 10 minutes after the prepared meal.  Subjects fed the astaxanthin pill 
after the meal had an increase of two times in absorption than the group  given the pill before 
the meal.  Smoking also affected the astaxanthin in the blood which decreased compared to 
the nonsmokers (Okada et al., 2009).  
 In conclusion, bioavailability depends not only  on the structure of astaxanthin 
ingested and must be converted to free form for absorption to occur, but also be attributed to 
when astaxanthin is consumed, and lipid composition in food (Odeberg et al. 2003). 
 
TOCOPHEROLS AND TOCOTRIENOLS
 Tocotrienols and tocopherols are fat-soluble vitamins and generically named as 
vitamin E, whose antioxidant properties are well studied.  Within the vitamin E analogs, α-
tocopherol is considered the most active form (Theriault et al., 1999).  Bioavailability of 
vitamin E is greatly influenced by food matrix, formulation, and food processing (Reboul et 
al., 2006).  Vitamin E food sources include, sunflower seeds, almond, and hazelnuts (Reboul 
et al., 2006).  Vitamin E cannot be synthesized in the human body therefore must be obtained 
from the diet  (GRAS 307, 2011).  Tocopherols are present in corn, wheat, and soybeans 
where tocotrienols are present in barley, oats, palm, and rice bran (Aggarwal et al., 2010). 
For our study, we used Tocomin® 50%, an oil extracted from virgin crude palm oil (Elaeis 
guineensis), containing predominately  α, β, γ, δ tocotrienol.  The Tocomin® 50% composition 
is illustrated in Table 2. 
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 Vitamin E Deficiency.  A lack of vitamin 
E in the diet can result in degenerative disease 
such as ataxia, Duchenne muscular dystrophy-like 
muscle degeneration, and infertility  (Aggarwal et 
al., 2010).  Vitamin E deficiency impairs 
myelinat ion of axons, increasing l ipid 
peroxidation of the mitochondrial membranes of 
sensory neurons (Brigelius-Flohé and Traber, 
1999; Meydani et al., 2003).  The nerve cells’ 
death is likely  due to the increase of nitric oxide 
production that is characteristically  seen in ataxia, 
vitamin E deficiency syndrome (Meydani et al., 
2003). Anemia occurs predominantly  in infants 
due to free radical damage likely because of 
insufficient vitamin E stores (Meydani et al., 2003).  Hypercholesterolemic subjects who are 
marginally  or severely deficient in vitamin E have decreased erythrocyte life span and 
increased susceptibility to peroxide-induced hemolysis (Brigelius-Flohé and Traber, 1999). 
In cystic fibrosis patients who have vitamin E deficiency, the plasma levels of 
malondialdehyde and hydroperoxide, lipid peroxidation, and protein carbonyls, are markers 
for protein damage (Meydani et al., 2003).  Skeletal muscle fiber damage is done by the loss 
of calcium homeostasis leading to dystrophic conditions (Meydani et al., 2003). Goss-
Sampson et al. (1998) observed the defects in retinal function in experimental animals.  The 
irreversible loss of long-chain PUFA from the retina, increased lipid peroxidation, and 
alternation in membrane fluidity were observed.
 The deficiency can occur as a result of genetic abnormalities in the α-tocopherol 
transfer protein (α-TTP) (Brigelius-Flohé and Traber, 1999).  People with the genetic 
modification of α-TTP have dramatically lower plasma vitamin E levels and will likely have 
neurological disorders, characteristic of the deficiency (Brigelius-Flohé and Traber, 1999). 
 The mutation in the ttpA gene causes the protein to not function properly (Manor and 
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Table 2. Composition of 
Tocotrienols and Tocopherols in 
Tocomin® 50%
Analogs Composition in 
Palm Extract 
(mg/g)
d-α-tocotrienol
d-β-tocotrienol
d-γ-tocotrienol
d-δ-toctrienol
d-α-tocopherol
d-β, γ, δ-tocopherol
Total tocotrienol 
tocopherol
115
15
210
55
115
3
513
Adapted from Carotech Inc. spec sheet.
Morley, 2007).  The extreme hydrophobicity of the tocopherols poses a major 
thermodynamic barrier for its distribution and transportation through the cytosol and 
circulation.  Vitamin E plasma levels do not respond linearly, suggesting other factors may 
regulate vitamin E levels (Manor and Morely, 2007).  
 Typically vitamin E deficiency rarely  occurs in humans with the cause not from 
dietary deficiencies as it  typically  takes years for normal individuals to develop clinical 
symptoms (Brigelius-Flohé and Traber, 1999; Meydani et  al., 2003).  Disorders associated 
with vitamin E deficiency include: chronic cholestatic liver disease, abetalipoproteinaemia, 
cystic fibrosis, chronic pancreatitis, progressive systemic sclerosis, short-bowel syndrome, 
isolated vitamin E deficiency syndrome, and other malabsorption disorders (Meydani et al., 
2003).  Individuals most  at  risk besides those with the previously  mentioned disorders are 
newborn infants, particularly premature babies with low body weight, and the elderly.  For 
infants, the placental transfer of vitamin E is poor for the developing fetus and newborns 
usually  have about one-third plasma concentrations compared to adults (Meydani et al., 
2003).  Premature babies can have even lower concentrations.  Vitamin E status can be 
boosted by breast feeding (Meydani et al., 2003).  Elderly are at risk as a result of low overall 
dietary intake or low availability  of high-quality food (Meydani et al., 2003).  The symptoms 
caused by  vitamin E deficiency, can be ameliorated by  administering vitamin E doses up to 
2000 mg/day orally or through intramuscular injection over long time periods (Brigelius-
Flohé and Traber, 1999; Meydani et al., 2003).
 Structure of Tocopherols and Tocotrienols.  Structurally, tocopherols and 
tocotrienols share some resemblance with a common chromanol head and side chain 
occurring at  the C2 position, only distinguishable by their side chains (Theriault et  al., 1999). 
Tocopherols have a saturated phytyl tail while tocotrienols have an unsaturated isoprenoid 
side chain (Figure 5) (Theriault et al., 1999).  These compounds are further separated to 
individual compounds by Greek letter prefixes (α, β, γ, δ).  The structural name for α-
tocopherol is 2,5,7,8-tetramethyl-2-(4’,8’,12’-trimethyltricecyl)-6-chromanol and for α-
tocotrienol is 2,5,7,8-tetramethyl-2-(4’,8’,12’-trimethyltrideca-3’,7’,11’-trienyl)-6-
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chromanol.  The different analogues are known together as vitamin E (Aggarwal et  al., 
2010). 
 Mechanism.  The tocopherol compound is considered to be a first line of defense 
against cell membranes at early  stages of free radical attack (Lien et al., 1998). Vitamin E is 
an antioxidant which falls into the chain-breaking antioxidant category as it can interfere 
with one or more of the propagation steps in autoxidation (Burton and Ingold, 1986). 
Vitamin E neutralizes peroxyl and alkoxyl radicals that are generated during lipid oxidation 
(GRAS 307, 2011).  Tocopherols and tocotrienols can interact by binding directly or 
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Analog R1 R2
α-Tocotrienol/Tocopherol CH3 CH3
β-Tocotrienol/Tocopherol CH3 H
γ-Tocotrienol/Tocopherol H CH3
δ-Tocotrienol/Tocopherol H H
Figure 5.  Tocopherol and tocotrienol structures.  The 4 tocotrienols and 4 tocopherols share common R1 
and R2 groups.  Tocotrienols are different due to the unsaturated phytyl side chain as tocopherols have a 
saturated side chain.  Figure adapted from Theriault et al., 1999 and Burton and Ingold, 1986.
“Head” Phytyl “tail”
indirectly at the transcriptional, translational, or post-translational levels (Aggarwal et al., 
2010).
HEALTH BENEFITS OF VITAMIN E
 Vitamin E as an Antioxidant.  In the general steps of oxidation, α-tocopherol can 
intercept the peroxyl radicals quicker than polyunsaturated fatty acids. Figure 6 illustrates the 
three phases of the free radical chain mechanism for lipid peroxidation.  α-Tocopherol 
donates a phenolic hydrogen atom to the radical then converting it to a hydroperoxide.  The 
new tocopheroxyl radical formed is removed from the cycle by  reacting with another peroxyl 
radical to form an inactive, non-radical compound (Burton and Traber, 1990).  Burton and 
Traber (1990) also stated α-tocopherol can react approximately  200 times faster than 
butylated hydroxytoluene (BHT) and the head of the molecule is entirely responsible for 
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Figure 6. Scheme of free radical chain mechanism for lipid peroxidation using α-tocopherol as termination. 
antioxidant properties. With this ability  a small amount of α-tocopherol is needed to protect 
lipid molecules.  In biological membranes α-tocopherol exists approximately  one part per 
1,000 lipid molecules (Burton and Traber, 1990).  Recent studies suggest α-tocotrienol is at 
least three times more efficient than α-tocopherol as a peroxyl radical scavenger due to its 
more uniform distribution in membrane (Lanari et  al., 2004).  Antioxidant activities are 
mediated through the induction of antioxidant enzymes like superoxide dismutase, 
NADPH:quinone oxidoreductase, and glutathione peroxidase (Aggarwal et al., 2010).
 A study completed by Lee et al. (2009) examined the effect on exercise endurance and 
oxidative stress on forced swimming rats.  The rats were fed 25 mg/kg tocotrienol-rich 
fraction, 50 mg/kg tocotrienol-rich fraction, or 25 mg/kg d-α-tocopherol.  The rats fed the 
tocotrienol-rich fractions were able to swim significantly longer than the control.  Other 
biological factors were also measured.  The authors concluded the tocotrienol was able to 
improve the physiological conditions and reduce exercise-induced oxidative stress in rats.
 Another study  performed on rats induced with chronic lung lipid peroxidation by  
paraquat, a herbicide extremely toxic to plants and animals, was completed by Asmadi et al. 
(2005).  Tocotrienols and α-tocopherol were supplemented at 150 mg/kg pellet and 34 mg/kg 
pellet respectively.  Both diets significantly reduced lung malondialdehyde levels but did not 
affect lung edema.  Asmadi et al. (2005) concluded tocotrienols and α-tocopherol provide 
protection against paraquat toxicity.
 A study  by Naguib et al. (2003) examined the antioxidant activities of natural d-α-
tocopherol, mixed tocopherols and tocotrienols, with a formulation comprising of all forms 
of vitamin E, all providing 400 IU using oxygen radical absorbance capacity  assay. Their 
findings showed antioxidant activities of the mixed tocopherol and tocotrienols exhibited 
higher antioxidant activities than d-α-tocopherol alone.
 Vitamin E and Cardiovascular Disease (CVD).  Cardiovascular disease is a major 
cause of death in the United States (American Heart Association, 2011).  Vitamin E is 
thought to have a role in preventing atherosclerosis by inhibiting oxidation of low-density 
lipoproteins.  In a study completed by Stephens et al. (1996) examined the effects of high 
dose treatment of α-tocopherol on the reduction of myocardial infarction and cardiovascular 
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death in patients with established ischaemic heart disease.  A double-blind, placebo-
controlled study with 2,002 patients with proven coronary atherosclerosis were enrolled. 
Five hundred forty-six patients were given 800 IU daily, 489 were given 400 IU daily, and 
967 received the placebo.  The patients who received the treatment  showed an increase in 
plasma α-tocopherol levels.  From this study  the investigators concluded that  patients with 
coronary  atherosclerosis, α-tocopherol treatment significantly reduced the rate of nonfatal 
myocardial infarction with beneficial effects after one year of treatment.
 Another study completed by Stampfer et al. (1993) examined the protective potential 
of vitamin E against coronary  disease.  The observational study used 87,245 females nurses 
from 34-59 years of age and were free from any diagnosed cardiovascular disease or cancer. 
The study lasted eight years.  The data gathered did not prove a cause-and-effect relationship 
between coronary disease and vitamin E intake, however, it did suggest middle-aged women 
who used vitamin E supplements had a reduced risk of coronary heart disease.
 Lastly, a study completed by Lee et al. (2005) on 39,876 healthy U.S. women of at 
least 45 years of age were randomly assigned to receive vitamin E, aspirin, or a placebo. 
Patients who received the vitamin E were given 600 IU alternate days.  Results from this 
study had a significant reduction for cardiovascular death with no significant  reduction with 
myocardial infarction or stroke.
 Anticancer Properties of Vitamin E.  Vitamin E has had great success to suppress 
proliferation and induce apoptosis in tumor cells in tissues such as breast, colon, liver, lung, 
stomach, skin, pancreas, and prostate (Aggarwal et al., 2010).  Vitamin E can act by extrinsic 
or intrinsic pathways.  Extrinsic pathways involve the induction of death receptors, and 
intrinsic pathways involve mitochondrial depolarization (Aggarwal et al., 2010).  Another 
way vitamin E can cause apoptosis is by DNA fragmentation in certain cells (Aggarwal et al., 
2010).  Some of the forms, γ- and δ-tocotrienols exhibit higher anticancer activity, than that 
of α- or β-tocotrienol (Aggarwal et al., 2010).
 A study  by Nesaretnam et al. (2008) examined the effect of tocotrienols on apoptotic 
signals in androgen-independent PC-3 human prostate cancer cells.  The researchers 
investigated the effect of tocotrienol-rich fraction from palm oil, α-tocopherol, α-tocotrienol, 
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γ-tocotrienol, and δ-tocotrienol on PC-3 cell growth.  After discussing at several other 
factors, Nesaretnam et al. (2008) came to the conclusion tocotrienols are able to induce 
apoptosis and cell cycle arrest in PC-3 cells with increased expression of Fas receptor, Fas 
ligand, caspase 8, caspase 3, and bax.  From this study  they suggest tocotrienols have a 
potential role in chemoprevention of prostate cancer. 
 A study  examined the synergistic effects of γ-tocotrienol and statin on mammary  
tumor cells.  Statins are a drug used typically  for lowering high blood cholesterol, yet there 
have been recent developments showed that the compound can induce cell cycle arrest  in 
vitro and inhibit tumor growth in vivo (Wali and Sylvester, 2007).  The problem with using 
statin is due to their high-dose toxicity.  Wali and Sylvester (2007) studied the combination of 
low dose treatment of γ-tocotrienol and statin on mouse mammary  epithelial cells.  A 
combined treatment dose of 0.25-2 µM resulted in a dose-response inhibition.  Tests with the 
statins or γ-tocotrienol alone had no effect, therefore, the conclusion was the combination of 
a low-dose treatment of γ-tocotrienol and statin may have a potential to treat breast cancer 
without causing myotoxicity.
 Another study  evaluated γ-tocotrienol anti-tumor activity on human hepatoma Hep3B 
cells.  Sakai et  al. (2006) studied α-, δ-, and γ-tocotrienol (25, 50 and 75 µM) and found low 
levels of γ-tocotrienol and shorter treatments than α-tocotrienol were able to inhibit cell 
proliferation.  The researchers also found caspase-8 and caspase-9 were also involved in 
apoptosis induction.  Bax and Bid, pro-apoptotic proteins, were involved in the regulation of 
apoptosis induced by γ-tocotrienol (Sakai et al., 2006).
 Neuroprotective Properties of Vitamin E.  The brain responses to injury  by  activating 
glia, releasing pro-inflammatory cytokines, and other glia-derived factors. Once the activated 
microglia accumulate, it contributes to neurotransmitter systems, such as glutamate, γ-
aminobutyric acid, and serotonin (Li et al., 2001).  Understanding these pathways will help 
identify  therapeutic targets and potential treatment strategies for neurodegenerative 
conditions.  There is evidence that vitamin E protects neurons against oxidative stress and 
might help prevent the development of Alzheimer’s disease (Li et al., 2001).  The authors 
examined the interactions between microglial-neuronal and pathogenesis of 
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neurodegenerative diseases like Alzheimer’s disease.  They used a microglial-neuronal 
coculture.  From the study, they concluded that  vitamin E provides direct antioxidant 
protection for neurons and may provide neuroprotection in vivo through suppression of 
signaling events. 
 A study by  Shichiri et al. (2007) examined the effect of tocotrienols and tocopherols 
on methylmercury  neurotoxicity.  Cerebellar granule cells were used to determine the 
methylmercury induced neurotoxicity.  Significant protection against cell death was observed 
with tocopherols and tocotrienols.  Tocotrienols also illustrated to be multi-fold more potent 
than tocopherols.  When micromolar concentrations were examined, tocotrienols exhibited 
protection by antioxidant mechanisms.  Both tocotrienols and tocopherols did show a 
protective effect on the cerebellar granule cells against the toxicity from methylmercury, 
therefore, both tocopherols and tocotrienols offered pharmacological protection for the brain 
against methylmercury (Shichiri et al., 2007).
 A study by Osakada et al. (2004) used palm oil to investigate the effects of vitamin E 
on oxidative stress and apoptosis using primary neuronal cultures from rat striatum.  They 
found vitamin E significantly reduced hydrogen peroxide induced neuronal death.  Each of 
the different analogs was purified from the palm oil and examined individually.  All the 
tocotrienols significantly decreased hydrogen peroxide induced neurotoxicity, but α-
tocopherol did not. α-, γ-, and δ-Tocotrienols had protection against cytotoxicity of 
superoxide donors, paraquat, and nitric oxide donors.  α-Tocotrienol only prevented oxidative 
stress-independent apoptotic cell death, DNA cleavage, and nuclear morphological changes. 
Among all the analogs and the examined oxidative stress and apoptosis, α-tocotrienol 
exhibited the most potent  neuroprotective properties with the rat striatal cultures (Osakada et 
al., 2004).  
 Vitamin E has also been linked to reduce bone loss, immunomodulatory functions, 
gastroprotective effects, anti-aging, and relieving skin disease (Aggarwal et al., 2010). 
Tocotrienols have specifically been linked to neuroprotection, cholesterol lowering, blood 
pressure lowering, anti-aging, antioxidant, anticancer, anti-angiogenic, anti-inflammatory, 
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immune function, modulation obesity, osteoporosis, eye, and bone health (Sen et al., 2006). 
Sen et al. (2006) has a comprehensive list of the studies on these health issues.
SAFETY CONCERNS OF TOCOTRIENOLS AND TOCOPHEROLS
 Currently tocotrienols are not listed on the GRAS-affirmed substance list in the U.S., 
however, the dietary supplements containing tocotrienols have been on the market since 1999 
under the Dietary Supplements Health and Education Act of 1994.  Palm tocotrienols have 
been tested for safety and toxicity.  A study of chicks for 5 weeks indicated safe intake levels 
up to 1,000 mg/day (GRAS 307, 2011).  Other animal studies have included both female and 
male rats with no abnormalities over varying lengths of time ranging from 14 days to 52 
weeks.  A study by  Tasaki et al. (2008) observed no abnormal effects in either male or 
females rats with 0.4% palm tocotrienol rich fractions in the diet.
 Besides numerous animal studies, there have been a number of clinical trials 
conducted using tocotrienol and tocopherols with few side effects reported (GRAS 307, 
2011).  Daily consumption level reported by the FDA up  to 330-360 mg of palm tocotrienol 
was not associated with any adverse effects in healthy  persons and persons with 
hypercholeterolemia or non-insulin-dependent diabetes mellitus (GRAS 307, 2011).
HUMAN BIOAVAILABILITY OF TOCOTRIENOLS AND TOCOPHEROLS
 Once ingested, tocotrienols and tocopherols are incorporated into chylomicrons in the 
intestine.  The newly absorbed tocotrienols and tocopherols are incorporated into very low-
density-lipoproteins in the liver.  The liver is responsible for the release and control of 
vitamin E into the blood.  α-Tocopherol is the most plentiful and most biologically active 
form of these compounds (Burton and Ingold, 1986).  Despite similar antioxidant functions 
for all the forms of tocotrienols and tocopherols, non-α-tocopherols are poorly  recognized by 
the hepatic α-tocopherol transfer protein (Traber and Atkinson, 2007; Manor and Morley, 
2007).  Table 3 illustrates the relative biological activities of vitamin E in rat resorption-
gestation test (GRAS 307, 2011).  Absorption efficiency  of lipophilic micronutients, like 
vitamin E, is highly variable and dependent due to the affinity of the α-TTP.   
36
 In a recent study by Leonard et  al. (2005), it was demonstrated γ-tocopherol is more 
rapidly metabolized in women than in men, where α-tocopherol is maintained in the plasma 
with little being metabolized. Despite the low affinity  for tocotrienols, there is evidence that 
oral supplementation of tocotrienols results in an increase of plasma tocotrienol 
concentration to 1 µM (O’Byrne et al., 2000).  
 
GALLUS DOMESTICUS DIGESTION
 Absorption efficiency from feed depends on a variety of factors.  For mammals, 
absorption can be summarized into four stages: digestion of food matrix, formation of lipid 
micelles, uptake into the intestinal mucosal cells, and finally delivery to the lymph system. 
For laying hens, this process is slightly different due to the lymphatic system is not 
developed (Surai et al., 2001).  Because of the lack of lymphatic system, carotenoids are 
most likely delivered to the liver and other tissues by  portomicrons, lipid-rich lipoproteins 
that are released from the intestinal cells directly into the portal vein (Surai et al., 2001). 
Once feed is ingested, carotenoids are released 
from the feed matrix by digestive enzymes. 
The newly  free carotenoids are emulsified with 
bile salts and pancreatic esterases to form oil 
droplets.  Since astaxanthin exists in free as 
esterified forms in the algae biomass, ester 
hydrolysis by pancreatic esterases occurs on the 
water-lipid interface (Surai et  al. 2001). 
Tyczkowski and Hamilton (1986 a) also 
reported the diester was partially  hydrolyzed in 
the intestine to both monoester and free form. 
These droplets are too large to gain proximity 
to the small intestine surface for absorption 
(Surai et al., 2001).  The oil droplets are then 
degraded to form mixed micelles containing 
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Table 3. Relative Vitamin E Biological 
Activities in Rat Resorption-Gestation
Compound Relative activity in 
prevention of fetal 
resorption (%)
d-α-Tocopherol
d-β-Tocopherol
d-γ-Tocopherol
d-δ-Tocopherol
d-α-Tocotrienol
d-β-Tocotrienol
d-γ-Tocotrienol
d-δ-Tocotrienol
100
25-50
1-11
1-3
29-30
5
Unknown
Unknown
Adopted from GRAS 307.
nonpolar and nonamphiphilic lipids where the micelles are able to interact with the intestinal 
lumen (Surai et  al., 2001).    The jejunum is the major site of lipid absorption in birds, yet 
some absorption also occurs in the ileum (Surai et  al., 2001).  Tyczkowski and Hamilton 
(1986 b) studied the effect of absorption of zeacarotene, cryptoxanthin, and lutein.  They 
concluded cryptoxanthin compared to lutein in the serum was 15.8:1 and 14.2:1 in the toe 
webbing.  Results from the same study were able to illustrate lutein and zeacarotene were 
absorbed in different areas of the intestine.  Zeacarotene was mainly absorbed in the ileal or 
middle region of the intestine, where lutein was absorbed mainly in the duodenum and 
jejunum or upper region of the intestine (Tyczkowski and Hamilton, 1986 b). The lipid can 
diffuse into the glycoprotein layer surrounding the microvilli and encounter the epithelial 
cells (Surai et al., 2001).  The type of feed can determine bile secretion and micelle formation 
(Surai et al., 2001).    The pH of the intestinal lumen can also affect absorption by changing 
the surface charges of the micelles and luminal cell membrane.  Low pH values allow for 
better diffusion (Surai et al., 2001).  Other soluble proteins and peptides from feed can aid 
with carotenoid dispersion.  Other fat in the diet provides a vehicle for transportation of the 
carotenoids or other lipid molecules from the gizzard to the intestinal tract (Surai et al., 
2001).  Once the carotenoids have been absorbed, they are transported to the liver where the 
portomicrons partly  undergo some transformation in the liver.  Most likely they are released 
into the circulation unchanged or with minor changes (Surai et al., 2001).  Carotenoids 
accumulate in the liver as a complex mixture of lutein monoesters and diesters as determined 
by Tyczkowski and Hamilton (1986 a) in young broiler chickens.  Carotenoid absorption is a 
delicate process, which can be hindered by impairing any stage in the process or promoted by 
lipid solubilization or micelle formation (Surai et al., 2001).
 Nine factors are identified that influence carotenoid bioavailability.  These factors 
include: species of carotenoid, molecular linkage, amount of carotenoids consumed from the 
feed, feed matrix, absorption effectors and bioconversion, nutrient status of the organism, 
genetic factors, host-related factors, and nutrient interactions (Castenmiller and West 1998). 
Naturally occurring carotenoids in plant foods are in the all-trans isomer.  Cis isomers are 
more polar, less prone to crystallization, and more soluble in oil and hydrocarbon solvents, in 
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general.  Molecular linkage is important for carotenoid esters.  The intestinal tract is unable 
to absorb esterified forms of carotenoids but has the necessary esterases to make the cleavage 
for the enterocyte to absorb the nutrients (Castenmiller and West, 1998). The amount of 
carotenoids in the feed relates to the dose-response relationship  between the carotenoid and 
the serum concentrations.  More carotenoids can be absorbed when consumed throughout the 
day rather than just a one time administration (Castenmiller and West, 1998).  The food 
matrix can drastically influence the bioavailabilities of astaxanthin, tocopherols or 
tocotrienols.  Lipid soluble carotenoids dissolved in oil are more readily  absorbed than in a 
non-lipid matrix (Castenmiller and West, 1998).  Optimal uptake of vitamin E and α- and β-
carotene requires a limited amount of fat  where lutein esters require more fat (Roodenburg et 
al., 2000).   Zeaxanthin, pigment found in corn, is three times better absorbed than 
astaxanthin (Schiedt et. al., 1985; Goodwin, 1986). The availability and the interactions with 
other carotenoids can affect the absorption of these compounds (van het Hof et al., 2000). 
Absorption of carotenoids can be drastically impacted by the variety of other nutrients 
consumed together.  Since vitamin E and astaxanthin are fat soluble the absorption and 
bioconversion could be greatly reduced with a low fat intake.  Dietary fiber can also affect 
the absorption by methyl esterification of pectin in hens which is important in determining 
absorption inhibition.  Dietary fiber change the bile acid interactions, resulting in increased 
fecal excretion of bile acids, thus, decreased carotenoid absorption (Castenmiller and West, 
1998).  Cofactors needed for the bioconversion of the carotenoids are important otherwise 
inhibition occurs not allowing the nutrient to get into the serum (Castenmiller and West, 
1998).  Genetic factors can play  a role, where one organism will have lower concentrations in 
the plasma even if it consumes the same amount as another organism (Castenmiller and West, 
1998).  Lastly, host-related factors include the effect of gender, sex, fat maldigestion and 
malabsorption (Castenmiller and West, 1998).
 Generally carotenoid absorption and accumulation in chickens is low.  In broilers, 
94% of astaxanthin supplied by  the diet were excreted and only  0.4% were deposited in the 
skin (Hencken, 1992).  In laying hens, egg yolk deposition of astaxanthin is only  14% and 
excretion about 70% (Hencken, 1992).  The free alcohol form would deposit in the egg yolk 
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(Tyczkowski and Hamilton, 1986 a).  Astaxanthin transfer depends on the source. 
Astaxanthin from yeast Phaffia rhodozyma, and marigold extract added to quail diet 
transferred only 4% and 3%, respectively to the egg yolk (Johnson et al., 1980).  In laying 
hens tissue carotenoid concentrations are found in decreasing order from the liver, abdominal 
fat, kidney, spleen heart, lung, and muscle (Surai et al., 2001).  Unused astaxanthin is not 
oxidatively metabolized but reduced to idoxanthin and crustaxanthin, which are quickly 
disposed of by the liver (Goodwin, 1986).
 α-Tocopherol may  interfere with tocotrienol absorption therefore increasing the 
binding capacity over γ-tocopherol and α-tocotrienol by 8-11 times (Lanari et al., 2004). A 
protein, α-tocopherol transfer protein (αTTP) has been identified to bind vitamin E analogs 
and transfer the compounds between membranes in the liver cytosol of animals.  Hosomi et 
al. (1997) examined the affinities of αTTP toward different tocos and calculated taking α-
tocopherol as 100%: β-tocopherol 38%, γ-tocopherol 9%, δ-tocopherol 2%, and α-tocotrienol 
12%.  The αTTP specifically sorts for the RRR-α-tocopherol (Brigelius-Flohé and Traber, 
1999).  Packer et al. (2001) also concluded that liver preferentially enriches VLDL with α-
tocopherol, discriminating other tocopherols and tocotrienols.  The metabolism of vitamin E 
is unclear.  Excess α-tocopherol is converted into α-CEHC (2′-carboxyethyl-6-
hydroxychroman) and excreted where other tocopherols, γ- and δ-tocopherol, are degraded 
and excreted through the urine as the corresponding CEHCs (Traber and Atkinson, 2007).
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CHAPTER 3. SUPPLEMENTATION OF LAYING HEN FEED WITH 
TOCOPHEROLS AND ALGAL (HAEMATOCOCCUS PLUVIALIS) 
ASTAXANTHIN FOR EGG YOLK NUTRIENT ENHANCEMENT
Modified from a paper to be published in 
Journal of Agricultural and Food Chemistry
Laurie Walker1, Tong Wang1, 2, Hongwei Xin3, and David Dolde4
ABSTRACT
 Adding supplements to hen feed can increase egg nutritional value.  Research on 
astaxanthin, tocotrienols, and tocopherols indicates this compound is a potent antioxidants 
and provides health benefits to humans.  We hypothesized that the addition of these nutrients 
to hen feed will result in egg yolks with increased nutrient content with minimum change in 
functional properties.  Laying hens (W-36 breed) were fed four diets with different 
supplementation levels of palm toco concentrate and algae (Haematococcus pluvialis) 
biomass containing astaxanthin for eight weeks.  Egg yolks were analyzed for physical (color 
and Haugh unit), chemical (fatty acid composition, phospholipids by  31P NMR, 
quantification of tocotrienols, tocopherols, and astaxanthin by HPLC), and functional 
properties (texture, emulsification, viscosity, and sensory evaluation).  Feed with the highest 
nutrient concentration was also studied for stability of these antioxidants using the Arrhenius 
approach.  No significant differences were observed among functional properties, except 
emulsification capacity and sensory characteristics among eggs from different diet 
treatments.  Emulsification capacity decreased as the concentration of feed additives 
increased.  Changes in egg yolk color achieved maximum values at day  8.  Incorporation of 
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tocopherols and tocotrienols increased until day 8 and astaxanthin incorporation increased 
until day  10, then decreased slightly thereafter.  Feed nutrients resulted in a dose-response 
relationship  of these in the egg yolk.  Transfer efficiency ranged from 0-9.9% for tocotrienols 
and tocopherols and 7.6-14.9% for astaxanthin for their peak values.  Sensory evaluation  of 
cooked eggs showed a significant difference in perceived sulfur, fishy  flavor, astringency, 
and lumpy levels.  No significant difference was shown with dryness and hardness 
characteristics.  Results from the Arrhenius accelerated stability  study showed significant 
differences in shelf-life of various nutrients and such results can be used to properly 
formulate the feed materials.  
Key words: Astaxanthin, egg quality, nutrient transfer, tocopherols, tocotrienols
INTRODUCTION
 Hen’s egg is recognized as one of nature’s most complete foods.  Eggs contain high-
quality protein and lipids as well as essential and nonessential nutrients.  They are an 
inexpensive food, food ingredient, and consumed worldwide.  Egg composition can be 
altered by heredity  genes, diet, and laying hen age (Frediksson et  al., 2006).  Egg yolk 
contains natural carotenoids, and its yellow color is attributed to the presence of β-carotene, 
zeaxanthin, crypotoxanthin, and lutein naturally found in commercial feed (Huopalahti et al., 
2007).
 Astaxanthin (3,3’-dihydroxy-β,β-carotene-4,4’-dione) is a dark-red pigment, and a 
member of the carotenoid family.  It is the main carotenoid found in algae, such as 
Brevibaterium, Mycobacterium lacticola, Agrobacterium auratim, Haematococcus pluvialis, 
and Phaffia rhodozyma (Domínguez-Bocangegra et al., 2004), and aquatic animals including 
salmon, trout, shrimp, lobster eggs, zooplankton, and birds, such as flamingo and quail 
(Johnson and An, 1991).  Astaxanthin has a strong antioxidant activity, 10 times higher than 
β-carotene and more than 300 times more effective compared to α-tocopherol (Rao et al., 
2009, Higuera-Ciapara et al., 2006; Miki, 1991).  Astaxanthin from Haematococcus pluvialis 
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is an excellent  source not only for pigmentation, but also to protect against lipid oxidation, 
UV photoxidation, inflammation, cardiovascular disease, and cancer (Guerin et al., 2003).
 Tocotrienols and tocopherols (tocos) are fat-soluble vitamins and generically regarded 
as vitamin E, for which the antioxidant properties are well studied.  Within the vitamin E 
analogs, α-tocopherol is considered the most active form (Theriault et al., 1999). 
Bioavailability of vitamin E is greatly influenced by food matrix, formulation, and food 
processing (Reboul et al., 2006).  Vitamin E is thought to prevent atherosclerosis (Stephens et 
al., 1996), protect against coronary  disease (Stampfer et al., 1993), prevent neurons from 
oxidative stress and the development of Alzheimer’s disease (Li et al., 2001), reduce bone 
loss, modulate immunomodulatory functions, protect GI tract, slow aging, and skin disease 
development (Aggarwal et al., 2010).
 Previously astaxanthin has been used successfully  in adding pigmentation to egg 
yolks, salmon, trout, and chicken meat.  A study  by Akiba et al. (2000) examined the effects 
of feeding yeast, Phaffia rhodozyma, that contains astaxanthin to increase the color of egg 
yolk.  They  used very low concentrations of astaxanthin, 0, 2, 4, 8, and 16 ppm for 4 weeks 
to feed hens and increased the yolk color score from 6.6 (golden yellow) to 12.7 (orange) on 
the Roche color fan.  Dike et al. (1992) completed a similar study using laying hens with 
0.3% Phaffia rhodozyma for 8 months and increased the Roche color fan score by  only 1 
point taking the color from a yellow to a more golden yellow.  Takahashi et al. (2004) 
evaluated the effect of astaxanthin from Phaffia rhodozyma feed containing 0, 50, or 100 mg/
kg of astaxanthin to broilers over two weeks.  Broiler tissues were examined for astaxanthin 
concentration with the highest concentration in the small intestine followed by subcutaneous 
fat, abdominal fat, spleen, liver, heart, kidneys, and skin.  The lowest astaxanthin 
concentration resided in the muscle. 
 Astaxanthin has been used to pigment other tissues besides egg yolks.  A study by  
Gobantes et al. (1998) used 5% astaxanthin to fed rainbow trout (Oncorhynchus mykiss) to 
examine the color stability in vacuum packaging over storage time.  They found considerable 
color variations among the neck, tail, and back parts along the fish but  failed to maintain the 
color over 15 day storage time.  Another fish pigmentation study by Barbosa et al. (1999) 
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evaluated the blood of rainbow trout (Oncorhynchus mykiss) by  feeding the fish two different 
sources of astaxanthin, green algae Haematococcus pluvialis and commercial beadlets of 8% 
astaxanthin.  They were able to achieve serum levels of astaxanthin from 5.3-9.0 µg/ml, and 
higher astaxanthin serum levels were achieved when fish were fed a high lipid content diet, 
independent of astaxanthin source.  Therefore, the majority of the past research with 
astaxanthin is for pigmentation, not for nutrient enrichment.
 Regarding vitamin E, there have been several feeding studies on vitamin E enriched 
feed for the nutrient to transfer to eggs, current  literature is not comprehensive on transfer 
evaluation among the different vitamin E analogs.  Flachowsky et al. (2002) examined the 
effect of α-tocopherol concentration on foods of poultry origin, and found that eggs had the 
highest levels of α-tocopherol.  A study by Franchini et al. (2002) successfully  used DL-α-
tocopheryl acetate, to increase its level in eggs.  Galobart et al. (2001) also used α-tocopheryl 
acetate to a base diet containing linseed oil to determine its transfer to eggs and they showed 
a dose-dependent enrichment with the range of 16-132 µg/g in whole egg.  Grobas et al. 
(2002) used α-tocopheryl acetate and vitamin A to the diet to assess the supplementation 
levels in the egg yolk, and found that α-tocopherol was deposited in the egg yolk.  All these 
feeding studies were focused on α-tocopherol transfer to eggs, not the tocotrienols, which 
have health benefits that are different from those offered by tocopherols (Aggarwall et  al., 
2010).
 Since tocotrienols possess powerful neuroprotective, anticancer, and cholesterol 
lowering properties that are not often shown by tocopherols. Osakada et al. (2004) showed 
that all the palm tocotrienols significantly decreased hydrogen peroxide induced 
neurotoxicity, but α-tocopherol did not.  γ-Tocotrienol antitumor activity on human hepatoma 
Hep3B cells, was shown by Sakai et  al. (2006).  Lee et al. (2009) showed that rats fed the 
tocotrienol-rich fractions were able to swim significantly longer than those fed α-tocopherol. 
Tocotrienols was also linked to cholesterol lowering, blood pressure lowering, anticancer, 
anti-angiogenic, anti-inflammatory, and immune function modulation (Sen et al. 2006). 
Despite knowledge of many health benefits of tocotrienols, we intended to examine their 
transfer from feed to egg yolks.  
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 It is expected that successful incorporation of both astaxanthin and tocos in eggs will 
further improve egg nutrition and human health.  We proposed to test how well these 
nutrients can be transferred to eggs.  We hypothesized the addition of astaxanthin, 
tocotrienols, and tocopherols will result in egg yolks with increased nutrient content with 
minimum change in functional properties. 
MATERIALS AND METHODS
Feeding Experiments 
 An 8-week feeding experiment was performed with 72 laying hens (Hy-Line W-36) 
of 35 weeks old at the start  of the experiment.  Iowa State University Institutional Animal 
Care and Use Committee approved all techniques for this experiment.  The hens were 
allowed to adjust to the new surroundings and feeding system for one week.  An 
environmentally-controlled room (temperature of 16-31 °C) with 24 cages (8 stacks x 3 tiers 
per stack), three birds per cage (as the experimental unit) was used to house the hens 
(Appendix 1, Figure 1).  Eighteen hens were assigned per treatment (6 replicates for each 
treatment) for a total of three treatments and 18 hens for a control diet.  Daily lighting 
program conditions were controlled to 16 hours of light and 8 hours of darkness, as used in 
commercial operations.    Hen housing allowed the water containers to be shared but feed 
containers was allowed only for one cage.  With this arrangement, no feed could be cross-
contaminated between cages.  Slightly slanted floors allowed the eggs to roll for easy 
collection.  
 The base diet formulation met the white laying hens NRC (1994) nutrient 
recommendations.  A vertical feed mixer combined the base diet (Table 1) for 30 minutes. 
From the base diet ingredients, some corn and animal rendered oil was held back to mix in 
the Tocomin® 50% (Carotech Inc., Edison, NJ) (Table 2) and BioAstin, dry flake/powder 
(1.35% natural astaxanthin Cyanotech Corporation, Kailua-Kona, HI) (Table 3) in a Hobart 
mixer (model H-600; Hobart, Troy, OH).   The algae product is designed to be used for 
human, fish, and animal consumption.  Tocomin® contains naturally occurring mixture of 
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tocotrienols and tocopherols extracted and concentrated from virgin crude palm oil and palm 
fruits (Elaeis guineensis).
 The base diet was divided into four equal parts for each treatment.  To make Diet A, 
control, the withheld corn and fat were added back to the base diet.  The lowest diet 
concentration, Diet B, with 0.49% algae (as-is basis) and 0.012% Tocomin® added would 
yield astaxanthin and toco 1,081 ppm in yolk lipid assuming 100% transfer efficiency.  The 
middle diet concentration, Diet C, with 1.47% algae and 0.036% Tocomin® would yield 
astaxanthin and toco 3,245 ppm in yolk lipid assuming 100% transfer efficiency.  The highest 
diet concentration, Diet D, with 2.94% algae and 0.072% Tocomin® would yield astaxanthin 
and toco 6,490 ppm in yolk lipid assuming 100% transfer efficiency.  The horizontal mixer 
combined each diet for 20 minutes.  Feed was stored at 4°C when not used at the poultry 
farm.  Approximately a 6-day supply  was brought out to the farm when the feed levels 
became low.  The birds were fed and watered ad-libitum.  Daily  measurements included feed 
intake, egg production, and egg weight.  Weekly hen weight was also measured. 
Egg Physical Properties  
 Egg Production Measurements.  Scheduled daily  egg collection resulted in the 
previous 24-hour production data.  The number of eggs and feed consumption from one-
week’s collection were combined to calculate egg production rate and daily  feed intake.  No 
egg collection was done during the adaption period, of 1 week.  Once the study began, eggs 
from day  0, 2, 4, 6, 8, 10, 12, 14, 16, 17, 21, 28, 35, 42, 49, and 56 were collected for egg 
yolk total lipid extraction, color analysis, and egg moisture content from each cage.  Each 
three-hen cage eggs were combined to be one unit.  Throughout the experiment whole egg 
and egg yolk weight were recorded. 
 Eggs collected from different days after reaching steady-state color enrichment were 
used for different tests to compare diet effect, because it is not  possible to perform all 
analyses with the small number of eggs produced from one day.
 Color Analysis.  Egg yolk separation from albumen was completed with a small 
strainer and a micro spatula. Manual stirring homogenized the sample of combined three-hen 
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cage eggs.  A LabScan XE spectrophotometer with Hunter Lab system (Hunter Associate 
Laboratory Inc., VA) was used for color analysis.  The system conditions were set to D65 
(daylight 65), 10° standard observer, 2.00-inch port size, and 1.75-inch diameter area view 
conditions.  Certified standard black and white plates were used to calibrate the system.  The 
CIE L*a*b* scale was used for measurements where L* represents the lightness, (value of 
100 was white and 0 was black), positive a* represents red, negative a* represents green, 
positive b* represents yellow, and negative b* represents blue. Approximately ten grams of 
fresh sample was placed into a plastic petri dish (60 x 15 mm) with white tape covered 
cardboard sleeve to avoid light escaping the system.  
 HunterLab color analysis was also performed with hard-boiled yolk samples from 
collection day 39, 40, and 41.  Approximately seven grams of cooked yolk was used, because 
this quantity  matched the height from ten grams of fresh yolk samples.  Cooking was done by 
boiling eight eggs for eight  minutes.  Egg yolks were carefully separated from the white and 
shell, then mixed together for each cage to make a homogeneous mixture.  Samples were 
gently pressed into the petri dish to decrease surface area and light scattering.  All samples, 
fresh or hard-boiled, were measured once.
 Haugh Unit.  Eggs collected on days 51, 52, and 53 were used for Haugh unit 
measurement.     Eggs were analyzed after an 24 hour equilibration period in an 18 °C cooler. 
A standard USDA method (USDA Handbook: 75, 2000) was followed.  Each egg was 
weighed and broken onto a glass top over a reflective mirror.  Thick albumin measurements 
were taken immediately after the breaking the egg using a micrometer.  The Haugh unit was 
calculated using egg weight and thick albumin height, with the following equation:
HU = 100 log (H – 1.7*W0.37 + 7.6)
Where: HU=Haugh unit, H=Observed height of the albumen (mm), W=Weight of egg (g). 
Each egg was measured once then averaged within the cage for a unit value.
Egg Yolk Functional Properties
 Raw Egg Yolk Viscosity Measurement. Viscosity measurement was completed with 
eggs collected on day 44 with a Haake RS 150 Rheometer (ThermoOrion, Karlsruhe, 
54
Germany).  Careful separation of egg yolk from the white was done to not break the yolk 
membrane.  The yolk was rolled in filter paper (Whatman cellulose filter paper 4) to remove 
any remaining albumen.  The yolks from the same cage were combined and mixed by a 
stirring rod.  Approximately ten drops of egg yolk was used for each measurement.  Samples 
were placed between a plate (diameter of 35 mm) and attachment (PP35T) with a gap of 
1.000 mm. The rheometer was maintained at  25 °C.  Samples were examined with two 
viscosity  tests. The first  test with changing shear rate linearly from 0.10/s to 60.00/s for 30 
seconds.  These results were fitted to the following equation:
τ = κ * (γ/γo)n
Where τ [Pa] as shear stress, γ [s-1] as shear rate, γo as constant shear rate [s-1], κ [Pa] as 
consistency index, and n as flow index (Buxmann et al. 2010).  The second test used a 
constant shear rate at 60.00/s for 60 seconds to give the apparent viscosity measure. Each 
sample was subsampled in duplicate for each test.  
 Egg Yolk Texture Measurement. Egg yolk texture profile was measured on eggs 
collection day 38 and 45.  TA-XT2i texture analyzer (Texture Technologies, Scarsdale, NY) 
was used to evaluate hard-boiled egg yolk texture profile using Texture Expert software. 
Eggs were boiled as described before in the color analysis method.  The shell and white were 
removed carefully not to break the yolk.  The whole yolk was measured using a modified 
two-bite model (TPA) method of Juliano et al. (2007).  The system was fitted with probe 
TA-4 (3.8-cm diameter acrylic cylinder 20 mm tall), pretest speed of 2.0 mm/s, test speed of 
1.0 mm/s, posttest speed of 2.0 mm/s, and distance of 15.0 mm.  Each egg was measured 
once and then averaged within the cage for a unit value.  
 Characteristics measured include fracturability, hardness, cohesiveness, adhesiveness, 
springiness, and chewiness.  Fracturability (g) was determined as the force at the first 
significant break in the curve.  Hardness (g) was calculated by measuring the peak force 
obtained during the first compression cycle.  Cohesiveness (dimensionless) was determined 
by the ratio of the positive force area during the second compression to that of the first 
compression.  Adhesiveness (g*s) was determined by the first bite’s negative area, 
representing the work necessary to pull the probe away from the sample.  Springiness (mm) 
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was defined as the height  the yolk recovers during the time lapse between the first and 
second bites.  Chewiness (g) was calculated by the product of hardness, cohesiveness, and 
springiness (Bourne 1978). 
 Egg Yolk Emulsification Properties.  The method were adapted from Wang and 
Wang (2009).  Egg yolk, from collection day  47, 1.5% dwb (liquid yolk) suspension in 25 
mL was mixed with dyed (Sudan Red 2B about 4 ppm) soybean oil at constant rate of oil 
addition, 5 mL/min.  A Bamix brand handheld blender (Switzerland) continuously  mixed the 
oil and protein dispersion at the “low” speed until apparent phase inversion was observed, at 
which point the oil-in-water emulsion system lost viscosity.  The amount of oil added until 
phase inversion was used to calculate the emulsification capacity (EC, g oil/g yolk).
 For emulsion stability  measurement, the same dyed vegetable oil 8 mL was added 
into 32 mL of 1.5% yolk dwb suspension and mixed with the same handheld blender for one 
minute on the “high” speed setting.  From the resulting emulsion, 10 mL were transferred 
into a 15 mL plastic centrifuge tube with 0.5 mL marked intervals.  Emulsion stability (ES, 
%) was calculated by dividing non-separated volume by total volume after one day standing 
at ambient temperature, and it is expressed as percentage.
 Sensory Evaluation.  Thirteen panelists (7 males and 6 females college-aged 
students) completed sensory evaluation training lasting three hours.  For the training, 
characteristic standard definitions were defined and standard samples were placed along an 
unstructured 15-cm line scale (Figure 1).  The training session included egg yolks from a 
local grocery store, diet  A, diet D fresh eggs, and 2-week old diet D eggs stored at 4 °C.  The 
panelists agreed on the standard sample placement on the line during training.  Three tests 
replicates (three separate sessions) were completed in a standard sensory test facility under 
red light to reduce visual cues.  Characteristics measured include flavor profile (sulfur and 
fishy) and texture profile (hardness, astringent, lumpy, and dry) modified from Juliano et al. 
(2006).  Sulfur was described as rotten egg smell, fishy as seafood or fishy  smell, astringent 
as puckering quality, lumpy as cottage cheese texture, and dry as how little moisture is 
perceived from the yolk.  A general preference (likeness) test was also conducted using a 
rating scale of overall quality (10 excellent to 1 very poor) and overall flavor intensity  (10 
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bland to 1 extreme) (AOCS Cg 2-83. 1993).  A sample sensory  test sheet is shown in Figure 
1.  Eggs were cut in half exposing the yolk and one half from each of the feed Diets, A, B, C, 
and D, were given to the panelists.  Samples were placed in a random order.  Each panelist 
was tested three times with each sample.  A 3-digit random number identified egg samples 
with the key only known to the researchers in the sensory kitchen. 
Egg Chemical Properties
 Egg Yolk Lipid Extraction.  Egg yolk was separated and mixed as described before. 
Total lipids were extracted by using Folch extraction method (Folch et al., 1957).  Briefly, 6 
grams of fresh yolk was extracted three times with 2:1 chloroform:methanol.  DI water was 
then added to the separatory funnel volume ratio of 8:4:3 of chloroform:methanol:water and 
time was allowed for phase separation.  The organic layer was roto-evaporated and the 
resulting oil was weighed and transferred with hexanes into glass 22-mL vials.  Vials were 
stored at 4 °C in the dark until further analysis.  Each sample was extracted once.
 Egg Yolk Lipid GC Fatty Acid Composition Analysis.  Collection day 10 egg oil 
samples were determined for fatty acid methyl ester (FAME) composition.  The method was 
adapted as described by  Hammond (1991).  Two mL of benzene were added to the oil 
aliquots (3 mL) in hexanes to remove any  remaining water and solvent was evaporated with 
nitrogen until dry.  One mL of 1 M sodium methoxide was added to the vials and react for 
five hours at ambient room temperature.  Three mL of DI water and two mL of hexanes were 
added to stop the reaction and separate the FAME from the rest of the solution. The FAMEs 
were analyzed by GC (Hewlett-Packard 5890 Series II) with a flame ionization detector, a 
silica capillary column (15 m long, 0.25 mm internal diameter, 0.2 µm film thickness, 
SP-2330, Supelco, Bellefonte, PA).  The chromatographic parameters were: injector and 
detector temperature of 230 °C, oven temperature program was 140-200 °C at 10 °C/min 
with no hold time.  The carrier gas (He) was set  at 5.4 mL/min, the auxiliary  gas (He) at 19.4 
mL/min, H2 was at 13.9 mL/min and air at 426 mL/min.  The split ratio was 24:1 (Gerde et 
al., 2011).
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 31P NMR Phospholipid Quantification.  Concentrated egg oil samples (80-90 mg/
mL) from day 10 were used for the analysis.  The internal standard, triphenol phosphate 
(TPP) was added to the oil (approximately 10 mg was dissolved in 1 mL chloroform-d, 1 mL 
methanol, and 1 mL Cs-EDTA (0.2 N, pH 8.5)).  After vigorous shaking, the samples were 
centrifuged at 1,250 x g for 2.5 minutes.  The lower phase was transferred to a 5 mm NMR 
tube (Kimble/Kontes, Vineland, NJ).  A Varian VXR-400 spectrometer (Varian, Inc., Palo 
Alto, CA) with a Bruker Magnet (Bruker BioSpin, Billerica, MA) operating at  162 MHz was 
used to obtain 31P NMR spectra.  Egg lipid samples were analyzed with an inverse gated 
decoupling pulse sequence to suppress any nuclear overhauser effect.  The NMR scan 
conditions were as follows: pulse width, 22 µs; sweep width 9718 Hz; acquisition time, 1.2 s; 
relaxation delay, 10 s; and 256 scans.  All chemical shifts were recorded relative to TPP (δ 
-17.8).  MestReNova software (Mestrelab Research SL, Spain) was completed for data 
processing.  The phospholipid content (percent) in the extracted egg oil was calculated as 
follows: phospholipid content (%) = 100* [(phospholipids (g) in the concentrated oil)/
(starting oil weight (g))] (Yao and Jung, 2010).  
 Tocotrienols and Tocopherols HPLC Quantification.  Normal-phase HPLC (Waters 
Alliance 2695, Waters Corporation, Milford, MA) was used to determine tocotrienol and 
tocopherol concentrations of all oil samples dissolved in 1 mL hexanes.  The detector (Waters 
474 Fluorescence, Waters Corporation, Milford, MA) was set to an excitation wavelength of 
292 nm and emission wavelength of 335 nm.  Injection volume was 5 µL and run time of 22 
minutes.  The column (Phenomenex, Luna 3µ NH2 100Å, 150 mm long x 3.0 mm internal 
diameter) was set to 30 °C.  Tocopherol standards (Matreya) and tocotrienol standards 
(Davos Life Science) with standards concentrations of 0.05, 0.1, 0.2, 0.5, 1, 2.5, and 5 ppm 
had 0.995 linearity or greater coefficient for the calibration curves. The mobile phases were 
HPLC grade 100% isopropanol (solvent A) and 100% hexanes (solvent B).  The HPLC ran 
2% solvent A and 98% solvent B isocratically.  
 Astaxanthin HPLC Quantification.  Reverse-phase HPLC (32 Karat 8.0, Beckman 
Coulter Gold HPLC, Beckman Coulter Inc.) was performed to determine astaxanthin level in 
all extracted egg yolk oil samples dissolved in 1 mL 50:50 ethyl acetate:ethanol.  One mL oil 
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samples previously suspended in hexanes were evaporated with nitrogen in amber colored 
vials.  Samples were then placed into a vacuum oven to remove any remaining hexanes from 
the samples then weighted.  The UV/Vis detector (System Gold 16 Detector, Beckman 
Coulter Inc.) was set 450 nm wavelength.  Injection volume was 20 µL and run time of 50 
minutes at a flow rate of 1 mL/min.  The column (YMC carotenoid, Waters, 3µ particle size, 
250 mm long x 4.6 mm internal diameter, Waters Corporation, Milford, MA) was set to 25 
°C.  A linear gradient mobile phase of 81:15:4 methanol: methyl t-butyl ether: water (solvent 
A) and 6:90:4 methanol: methyl t-butyl ether: water (solvent  B) was used for lipid separation. 
The gradient program adapted from Sander et al. (1994) was used: linear decrease from 
100% of A to 77.8% A in 20 minutes, linear increase to 100% B from 20 to 23 minutes, then 
holding at 100% B until 35 minutes.  For preparation for the next sample, linear decrease 
from 100% to 0% B was completed in 5 minutes, and 10 minutes conditioning at 100% A.    
 Due to the lack of astaxanthin standard, β-carotene standard was used for 
quantification.  A standard curve was generated using 50, 100, 300, 600, 1000, 2000, 5000, 
and 7000 ppm β-carotene solutions and their HPLC areas.  Astaxanthin area was converted to 
β-carotene equivalents using extinction coefficient correction.  Astaxanthin’s extinction 
coefficient was reported as E1%1 cm = 2,100 for free, monester, and diester forms, while β-
carotene’s extinction coefficient was E1%1 cm = 2,600 (Barbosa et al., 1999; Yuangsoi et al., 
2008).
 Astaxanthin Identification by Liquid Chromatography-Mass Spectroscopy. 
Negative ion mode APCI mass spectrometer (6540 UHD Accurate-Mass Q TOF LC-MS, 
Agilent Technologies, Schaumburg, IL) with a diode array LC detector (450 nm) was used 
for egg oil and algae biomass extract xanthophyll identification with a method modified from 
Holtin et al. (2009).  The same separation conditions were used as described for the HPLC 
astaxanthin quantification.  The LC system (Agilent 1200 Series) delivered the solvent at a 
flow rate of 1 mL/min and 1 µL sample injection.  The MS was tuned and calibrated using 
the Agilent APCI tune mix.  Agilent MassHunter Software (Version B.0.3) was used to 
process data and identify the five astaxanthin isomers. 
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Nutrient Transfer Efficiency into Egg Yolk 
 Transfer efficiency calculation for each of the additives was completed as the ratio of 
milligrams of the additive transferred in the egg at the peak value to the milligrams of 
additive consumed during the same period.  The calculation of milligrams of additive 
consumed was concentration in feed (mg additive/kg feed) multiplied with the feed 
consumed (Galobart et al., 2001).
Shelf-life Study of the Feeding Material Using Arrhenius Approach
 Arrhenius Approach Degradation Kinetics.  The highest enrichment diet was used 
for this study for more easily detectable changes in concentration.  Approximately 100 g 
samples of Diet  D were placed into four different ovens set at 50, 60, 70, and 80 °C.  Time 
interval for sampling at each oven temperature were based on the Q10 = 2 rule.  Samples were 
taken every seven days for the 50 °C sample, five days for the 60 °C sample, three days for 
the 70 °C sample, and two days for the 80 °C sample.  The Arrhenius equation is as follows: 
k=Ae-Ea/RT
where k is the rate coefficient, A is a constant, Ea is the activation energy, R is the universal 
gas constant, and T is the temperature in Kelvin.  By  linearly correlating ln(k) vs. 1/T, the 
activation energy can be estimated and shelf life of the nutrient at any temperature can be 
estimated using the Arrhenius equation.
 Feed Lipid Extraction.  Diet D feed total lipids were extracted using the same Folch 
method mentioned for egg yolk oil extraction with a minor modification. A 9 gram sample 
was extracted using 50 mL of 2:1 chloroform:methanol for one hour covered to avoid light 
deterioration.  Mixtures were then filtered (Whatman cellulose filter paper 1) and extract was 
repeated two more times.  Solvent extracts were combined for Folch wash in a separatory 
funnel and covered with aluminum foil to minimize nutrient degradation for phase 
separation.
 HPLC Quantification of Astaxanthin in Feed Lipid. Reverse-phase HPLC was also 
performed on the feed lipid samples for astaxanthin degradation rate determination. The same 
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sample preparation as for egg yolk astaxanthin lipid quantification was used.  The same 
HPLC systems, software, column, and solvents were also used.  The gradient was the same 
as found in Sander et al. 1994 method, which was different from egg yolk astaxanthin 
quantification.  Briefly, 100% solvent A changed to 100% solvent B linearly over 90 minutes. 
Ten minutes of 100% solvent A followed each sample run to condition the column for the 
next run.  Astaxanthin in feed and algae biomass were mainly  in the monoester forms.  The 
total area of all the ester peaks were used for quantification.
Statistical Analysis
 Statistical analysis was completed using SAS (version 9.2, SAS Institute Inc., Cary, 
NC) One-way analysis of variance (ANOVA) was used for mean comparisons, and Fisher’s 
least significant differences were calculated at P< 0.05 (LSD0.05).  All treatments had six 
replicates.
RESULTS AND DISCUSSION
Feeding Experiment  
 After mixing the feed, the astaxanthin induced a color in the feed from a pale yellow 
to a burnt red color as seen in Figure 2.  The color is directly related to the amount 
astaxanthin-containing in the algae biomass added to the diet; the higher astaxanthin biomass 
added the more red the feed became.  
 Visual Observations at the Farm. Visual observations were made of the hen’s 
appearance.  Appendix Figures 2 and 3 shows observed color changes in the hens’ combs and 
feet respectively, during week 7 of the study.  The redness coloration differences can be 
linked to the astaxanthin pigment as seen in a broiler feeding study that showed similar 
results in meat with higher astaxanthin concentrations in the feed leading to more red 
coloration in the skin and muscle tissues (Akiba et  al., 2001; Takahashi et  al., 2004). 
Appendix Figure 4 shows the hens’ fecal matter darkening from the different treatment diets, 
as a result of incomplete absorption of astaxanthin.  The red intensity increased due to the 
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astaxanthin increase in feed.  Hencken (1992) found that 70% of astaxanthin fed was 
excreted.
Egg Physical Properties 
 Hen Performance and Egg Quality. Laying performance and egg physical quality 
parameters are shown in Table 4.  Laying rate, hen weight, egg yolk weight, moisture 
content, and Haugh unit for all the diets had no significant difference among the diets. The 
mean laying rate was above 90% for all the diets.   Laying rate percent (or hen-day egg) was 
calculated by  number of eggs produced/number of hens x 100.  Whole egg weight was not 
statistically  significant among Diets A, B, and D, but there was a difference with Diet C, 
whose eggs weighted slightly  less than the other diets.  Egg yolk weight for all the diets had a 
mean of 16 g/egg yolk and no statistical difference was found.  Yolk moisture content for all 
the diets was about 50% which matches the value found in literature (Huopalahti et al., 2007; 
Aro et al., 2009).  Haugh unit values were 88-89 for all the diet and these values are 
comparable to a study  completed by Franchini et al. (2002).  Feed intake was similar for all 
diets ranging from 104-106 g/day/hen.  Yet, it  increased slightly (not statistically significant) 
to a mean of 108 g/day/hen for Diet D.  Similar feed intake was seen with a study by 
Carrillo-Domínguez et al. (2005) fed red carb meal, containing astaxanthin to laying hens. 
Prayitno et al. (1997) reported that a higher intensity of red color encouraged the hens to 
consume more feed, and this may explain the seemingly higher feed consumption because of 
Diet D’s higher intensity of red color.  
 Yolk Color Enrichment.  Color analysis exhibited some interesting characteristics. 
All fresh egg yolk samples changed in L*, a*, or b* values but they became relatively 
constant after day  8.  A similar observation was made by Fredriksson et al. (2006) where N. 
oculata was added to their feed.  A glimpse of the color progression is displayed in Appendix 
Table 1.  Yolk color changes were noticeable by day 3.  Color started with the outer 
membrane of the yolk and further continued inward until the entire yolk was uniform. 
Samples decreased in L* value, to day 8 where each diet plateaued at different values, with 
the highest concentration diet being the darkest (Figure 3).  The a* values of yolk increased 
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drastically when the samples became more red with increasing feeding time and 
concentration, with Diet  D treatment having the highest  value of redness (Table 5).  The b* 
values exhibited smaller and slower changes among the different diets as compared to the L* 
and a* values.  These trends for the L*, a*, and b* values were similarly reported in 
Fredriksson et al. (2006) who fed the hens Nannochloropsis oculata, a green algae and 
Herber-McNeill and Elswyk (1998) who fed an enriched marine microalgal product.  Akiba 
et al. (2000) fed Phaffia rhodozyma, which contained astaxanthin and obtained similar trends 
as observed in this study, but their color change were not as drastic as the current study due 
to lower ppm concentrations fed to the hens.  Hard-boiled yolk samples showed the same 
trends in color analysis except the values were lower for a* and b*, and higher for L* 
(Table5) possibly due to cooking and protein denaturation. 
Egg Yolk Functional Properties
 Effect of Diet Enrichment on Yolk Viscosity.  The viscosity of raw egg yolks 
illustrated a shear thinning, pseudoplastic profile, as reported by Ibarz and Sintes (1989). The 
apparent viscosity showed no significant difference among the diets (Table 6).  The viscosity 
coefficients or consistency indexes were the same Diets A, B, and D, yet Diet C showed a 
higher value from unknown causes, because the amount of oil and moisture content were 
similar in eggs from all diets.  Viscosity coefficient is defined as the viscosity  at a shear rate 
or stress of 1 s-1.  From the power law model, the exponent, flow index, had no significant 
difference among diets.  The flow index is a measure of how a non-Newtonian fluid is.  If the 
index is 1 the fluid is Newtonian, index between 0 and 1 the fluid is shear-thinning, and index 
greater than 1 is shear-thickening.
 Effect of Diet Enrichment on Emulsification Properties.  Emulsification capacity 
and emulsion stability measure the amount of oil the protein suspension can emulsify and 
how stable the emulsion formed with a specific amount of oil, respectively.  There were no 
significant differences among the treatments for the stability test (Table 6).  The capacity did 
exhibited differences among the diets.  Diet A, the control, had the highest emulsification 
capacity Diet C and D had lowest  levels. This decrease cannot be explained.  The possibility 
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of the nutrient incorporation causing a different interaction between the oil and yolk protein 
would be low.  The possibility of the proportion of various types of yolk protein may have 
changed by diet may exist.  However, the focus of this study was only  on lipid components 
and how the yolk as a whole may have different properties, so the potential protein type, 
proportion or functionality change may be a focus for future studies.
 Effects of Diet Enrichment on Egg Yolk Texture. Texture measurements obtained 
were fracturability, hardness, adhesiveness, cohesiveness, springiness, and chewiness.  The 
egg yolks were analyzed individually, then averaged for cage values as unit values with 6 
replicates.  The texture test showed no significant difference among the diets for each of the 
parameters measured (Table 7).  Results were also similar to a study by Kassis et  al. (2010) 
that used krill oil containing astaxanthin, for egg enrichment, resulting in no significant 
differences in springiness, cohesiveness, gumminess, chewiness, and resilience.  Large 
standard deviations can be explained by  uneven cooking, yolk’s natural texture, or if the yolk 
started to break before the test was completed.
 Sensory Evaluation.  Appendix Figure 5 shows the hard boiled eggs after hard 
boiling used for the sensory panel. Data from the sensory panel are shown in Table 8. 
Perceived sulfur levels were noticeably lower with an increase of fishy  flavor for Diet D 
treatment.  The normal egg flavor change with this diet is due the high algae biomass 
concentration and the addition of the highly unsaturated fatty acids contained in the algae. 
Typical egg flavor is comprised from many compounds.  Macleod and Cave (1976) identified 
cooked egg yolk flavor compounds including 9 saturated and 8 unsaturated straight chain 
hydrocarbons, 1 alcohol, 3 carbonyls, 5 alkyl, 5 alkenylbenzenes, 3 phenols, 4 indans, 3 
indoles, 1 sulfide, 4 pyrazines, 3 pyrroles, and 4 nitriles.  The predominant compounds 
identified were 2-methylbutanal, 5-heptadecene, indole and toluene. Algal biomass has a 
fishy characteristic therefore the egg flavor was affected by  the astaxanthin addition.  No 
observed differences were found among diets for hardness.  This also correlates with the 
texture analysis performed.  Astringency  was significantly different for Diet B compared to 
the other diets, which was less astringent than the rest of the eggs, and the reason is 
unknown.  Astringent compounds in egg yolks are phenols like o-cresol, m-cresol, and p-
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cresol (Maga, 1982).  The lumpy characteristic was lower for Diet A, where Diet D was 
significantly the most lumpy, cottage cheese-like characteristic.  There was no significant 
difference in dryness among the diets.  The last  two parameters from the sensory panel (Table 
8) were not from trained evaluation, but were given as preliminary indicators of consumer 
acceptance.  The overall quality  was statistically significantly higher for Diet A and B than 
for Diet  D, but there no significant difference with overall intensity  flavor.  These differences 
are small, and may not be practically different.  A consumer level test should be done to 
assess acceptability.
Egg Chemical Properties 
 Fatty Acid Composition. Appendix Figure 6 illustrates a typical chromatogram from 
egg lipid FAME analysis.  Table 9 illustrates the GC results of fatty acid composition from 
day 10 of the feeding study.  All egg yolk oils were not significantly different and 
composition percentages are similar to reported values from USDA (2010) for fresh egg yolk.
 Diet Effect on Egg Yolk Phospholipids. Figure 4 illustrates a typical spectra from the 
31P NMR analysis.  There was good separation of various polar lipids classes as presented by 
Yao and Jung (2010) for identification and class quantification.  Cardiolipin, 
phosphatiylethanolamine, sphingomyelin, lysophophatidylcholine, phosphatidylinositol, and 
phosphatidylcholine were identified from the 31P NMR chromatogram.  Table 10 illustrates 
the phospholipid class composition and concentration relative to total oil from day 10 eggs. 
These phospholipid compositions are not significantly different among treatments.
 Astaxanthin Identification.  The monester and free astaxanthin HPLC peaks from 
algae lipid extract  are shown in Figure 5A.  The astaxanthin extract chromatogram is similar 
to that reported by  Holtin et al. (2009) and Miao et al. (2006), showing astaxanthin in algae 
are mainly  monoesters.  However, hens are able to convert the esters to free astaxanthin and 
deposit the free form in eggs.  The five isomers shown in Figure 5C are due to the cis and 
trans double bond configuration difference and the hydroxyl group orientation (Holtin et al., 
2009).  All astaxanthin peaks were confirmed by LC-MS (Appendix Figure 7).  The five 
isomers of astaxanthin are all-trans 3S, 3’S astaxanthin, all-trans 3R, 3’R astaxanthin, all-
65
trans 3S, 3’R astaxanthin, 9-cis astaxanthin, and 13-cis astaxanthin.  The sum of areas of all 
five peaks was used to calculate astaxanthin amount in egg yolk lipid extract.
 Diet Effect on Nutrient Concentration in Egg Yolk.  HPLC quantification was 
completed for tocotrienols, tocopherols, and astaxanthin (Figure 5B, C).  All toco analogs 
were well separated, as well as the major isomers of astaxanthin.  The additives’ 
concentration in yolk lipid increased as their concentration in feed increased (Figure 6 and 7) 
except for γ- and δ-tocopherols.  The increase in concentration continued until day  8 for Diets 
B, C, and D for all tocotrienols. However, tocopherols enrichment showed different profiles. 
At the end of the 56-day  feeding, many tocopherol concentrations tended to be lower than 
those at the start of the trial, especially for δ- and γ-tocopherols, which showed a steady 
reduction and for α- and β-tocopherol from the control and Diet B treatment.  The reason 
could be that in the palm toco concentrate (Table 2), there were negligible amount of β-, δ-, 
and γ-tocopherols (a total of 3 mg/g, 0.6% of total tocos).  However, the feed itself had its 
own natural tocopherols from the natural ingredients. With the added tocotrienols and α-
tocopherol, the absorption of the δ- and γ-tocopherols in the feed itself was greatly 
suppressed.  Because tocotrienols are not typically found in the natural ingredients in feeds, 
their feed enrichment led to a steady enrichment in eggs, and in a dose-response relationship. 
There seems to be a feedback or competitive inhibition for all the nutrients.  With α-
tocopherol there was a decrease between 30-65% depending on the diet.    Other compounds 
exhibited a more dramatic decrease, with δ-tocopherol having 75% reduction compared to 
the initial value.  Astaxanthin has a smaller decrease of 38-43% between Diet D and Diet B. 
A study by  Galobart  et  al. (2002) observed a decrease in α-tocopherol of 10-12% while 
Meluzzi et al. (2000) and Franchini et al. (2002) saw reductions similar to the current study 
of 30% and 20-55%, respectively.  Differences among the studies could be due to several 
factors including genetics, laying parameters, type and concentration of tocopherol used, 
experimental conditions, basal diets, and presence of other antioxidants (Meluzzi et al., 
2000).
 Astaxanthin increased in concentration up to day 10 for diets B, C and D and there 
was also a slight reduction thereafter (Figure 7). Astaxanthin had smaller decreases of 
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38-43% relative to peak values from Diet D to Diet B.  This may indicate that the feedback 
inhibition for this antioxidant is not as strong as for tocopherols.      
Nutrient Transfer Efficiency into Egg Yolk
 From HPLC quantification, transfer efficiency can be calculated.  Since day  8 and 10 
of the study exhibited the highest nutrient concentration for tocos and astaxanthin in yolk 
lipid, respectively, this data were used for the calculation of the highest efficiency.  Another 
two times were also selected to show the lower efficiencies and the results are shown in Table 
11.  The highest transfer efficiency occurred at  the lowest feed concentration for most of the 
compounds.  Efficiency  variation for different compounds can be attributed to the difference 
of bioavailability and biochemical processes.  A protein, α-tocopherol transfer protein (αTTP) 
has been identified to bind vitamin E analogs and transfer the compounds between 
membranes in the liver cytosol of animals.  Hosomi et al. (1997) examined the affinities of 
αTTP toward different tocos and calculated relative affinity taking α-tocopherol as 100%: β-
tocopherol 38%, γ-tocopherol 9%, δ-tocopherol 2%, and α-tocotrienol 12%.  Packer et al. 
(2001) also concluded the liver preferentially  enriches VLDL with α-tocopherol, 
discriminating other tocopherols and tocotrienols.  The present study  confirmed this trend, 
with the highest vitamin E analog transferred was α-tocopherol.  This transfer protein’s 
specificity could be the cause for this study failing to enrich the egg yolks sufficiently  with 
tocotrienols.  The low affinity of the transfer protein for α-tocotrienol in the presence of α-
tocopherol resulted in small amount of α-tocotrienol transferred from the feed to the egg. The 
other tocotrienols transferred were even lower (< 1%).  However, there is an interesting 
observation comparing the relative transfer efficiency of α-tocotrienol to α-tocopherol’s at 
different feed concentration: 17, 36, and 41% for Diet B, C and D. Apparently, at higher 
concentration, more tocotrienols may be forced into the circulation system.  These values are 
also higher than the 12% as reported by Hosomi et al. (1997).
 The α-tocopherol transfer efficiency exhibited the highest transfer at 9.9% in Diet B 
to 3.4% in Diet D.  Galobart et  al. (2001) also observed a decrease from 41.8% with 50 mg/
kg in the diet down to 26.7% with 200 mg/kg noting the highest transfer efficiency was 
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obtained with the lowest dietary level of α-tocopherol.  In our study, the amount of added 
total tocos in Diet B was 60 mg/kg, in C was 180 mg/kg, and in D was 360 mg/kg.  However, 
since α-tocopherol was only 22.5% of the total tocos, the added α-tocopherol in the three 
diets were 13.5, 40.5, and 81 mg/kg.  Therefore, our feed enrichment level is similar to that 
of Galobart el al. (2001) but with much lower transfer efficiency.  Similar trends were also 
confirmed in other vitamin E supplementations studies by Flachowsky et al. (2002) and 
Shahriar et al. (2008).
 Astaxanthin transfer efficiency rate was determined to be as high as 14.9% at the low 
enrichment level.  Its transfer efficiency reduced to 7.6% when the enrichment was increased 
6-fold in the diet.  Although the total concentration in yolk was increased by  the increase in 
enrichment, however, the efficiency  is greatly reduced.  Akiba et al. (2000) observed 3.6% 
efficiency from their study using Phaffia rhodozyma as a source of astaxanthin.  A study by 
Johnson et al. (1980) using the same yeast also observed from 3 to 4% efficiency  in laying 
quails.  Our data showed a higher transfer efficiency from algae biomass compared to red 
yeast.
 It should be noted that we used the peak concentration of the nutrients to discuss the 
maximum transfer efficiencies. In reality, a steady  state concentration, if observed, should 
have been used for such calculation. Since our concentrations showed steady reductions, and 
no plateaus were observed after 56 days, especially for the high enrichment concentrations, 
we decided to use the peak values for comparing the differences among different treatments.  
Shelf-life Study of the Feeding Material using Arrhenius Approach
 A shelf life study of Diet D was completed using the Arrhenius approach.  Figure 8 
and Appendix Figure 8 shows the shelf-life study.  The slopes from Arrhenius plots were 
used for activation energy determination.  Summary of the kinetics is shown in Table 12.  γ-
Tocopherol had an apparent zero order degradation reaction.  α-Tocopherol, α-tocotrienol, 
and δ-tocopherol were determined to have an apparent first order degradation reaction.  All 
the remaining compounds, β-tocopherol, β-tocotrienol, γ-tocotrienol, δ-tocotrienol, and 
astaxanthin, appeared to have an apparent second order degradation reaction.  Activation 
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energy ranged from 28 to 307 kJ/mol.    The half-life of each of the nutrient compounds are 
also presented in Table 12.  The half-lives of the nutrient compounds show that certain 
compounds had very  short half-lives, such as γ-tocopherol.  The longest half-lives were 
exhibited by astaxanthin and δ-tocopherol.  The low R2 values may be attributed to the 70 °C 
oven temperature fluctuation causing irregular degradation trend.
CONCLUSION
 This study shows astaxanthin and tocos can be incorporated into the egg yolk by 
different degrees of success by adding the ingredients into the feed.  The higher the 
concentration in the feed the higher the concentration in the resulting egg yolk, however with 
lower transfer efficiency.  Even though tocotrienols are nutrients with unique health benefits, 
they cannot be effectively transferred into eggs as α-tocopherol.  
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Table 1. Composition of Base Diet for Laying Hens
Ingredient Composition (%)
Corn
Soybean Meal
Coarse Calcium Carbonate
Fine Calcium Carbonate
Dicalcium Phosphate
Animal Rendered Oil
Vitamin and Trace Mineral Premix
Sodium Chloride
DL-Methionine
Crude Protein
Metabolizable Energy, kcal/kg
Crude fat
Linoleic acid
Calcium
Phosphorus (nonphytate)
Sodium Chloride
Chloride
Lysine (digestible)
Methionine (digestible)
Methionine + Cystine (digestible)
60.79
24.56
5.87
3.92
2.03
1.58
0.68
0.38
0.18
16.05
2,825
3.94
1.82
4.20
0.48
0.18
0.26
0.77
0.41
0.63
Premix includes per kilogram of diet: vitamin A, 9,000 IU; vitamin D3, 3,000 IU; vitamin E, 
20 IU; cobalamine, 13 µg; riboflavin, 6 mg; niacin, 45 mg; pantothenic acid, 12 mg; choline, 
487 mg; menadione, 1.2 mg; folic acid, 1.5 mg; pyridoxine, 1.2 mg; thiamine, 1.5 mg; biotin, 
45 µg; magnesium, 136 mg; manganese, 136 mg; zinc, 136 mg; iron, 140 mg; copper, 14 mg; 
and selenium, 0.27 mg.
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Table 2. Composition of Tocomin® 50%
Analogs Composition (mg/g)
d-α-Tocotrienol
d-β-Tocotrienol
d-γ-Tocotrienol
d-δ-Tocotrienol
d-α-Tocopherol
d-β, γ, δ-Tocopherol
Total Tocotrienol/Tocopherol
115
15
210
55
115
3
513
Composition of Tocomin® 50% from Carotech.  Information adapted from Carotech product 
specification sheet.
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Table 3. Composition of BioAstin
Components Composition (%) Components Composition (%)
Natural Astaxanthin
Total Fat
Protein
Carbohydrates
Dietary fibers
Moisture
Ash
Other Carotenoids 
Astaxanthin):
β-carotene
Canthaxanthin
Lutein 
1.35 Natural Astaxanthin:
20-25 Free Astaxanthin 1.9
20-35 Monoester 84.3
30-55 Diester 13.9
18
<9 Astaxanthin Isomers:
<17 Di-cis-astaxanthin 2.22
(relative to total Trans-astaxanthin 74.07
2.22 9-cis astaxanthin 6.66
1.48 13-cis astaxanthin 8.15
2.96 15-cis astaxanthin 0.74
Information adapted from ALGAtechnologies (1998) spec sheet, Cyanotech certificate of 
analysis (2010) and Cyanotech analysis report (2011).
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Table 6. Viscosity and Emulsification Egg Yolk Samples with Different Levels of 
Nutrient Supplementation
Diet1 Viscosity    
(kg/s*m) 
(n=12)2
Consistency 
Index (Pa) 
(n=6)2
Flow Index 
(n=6)2
Emulsification 
Capacity 
(average g oil/g 
yolk) (n=6)3
Emulsion 
Stability (%)
(n=6)3
A 
B
C
D
P-value
0.86 ± 0.32 4.26 ± 1.68 0.66 ± 0.08 62.00 ± 3.14 a 62.23 ± 6.71
0.75 ± 0.20 2.90 ± 1.35 0.64 ± 0.07 56.35 ± 2.16 b 61.00 ± 9.45
0.93 ± 0.22 8.08 ± 6.15 0.55 ± 0.13 53.98 ± 5.61 c 63.50 ± 7.18
0.82 ± 0.26 4.21 ± 4.76 0.64 ± 0.13 51.53 ± 1.21 c 58.17 ± 10.07
NS NS NS * NS
Values are mean ± standard deviation.
1 Diets are A=no supplements, B enriched with 0.012% tocomin and 0.49% algae biomass; C 
enriched with 0.036% tocomin and 1.47% algae biomass; and D enriched with 0.072% 
tocomin and 2.94% algae biomass.
2 Viscosity parameters analysis was completed on collection day 44. 
3 Emulsification properties analysis was completed on collection day 47.
Different letters in the same column indicate significant different at 95% confidence interval.
*P-value ≤ 0.05; NS - not significant.
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Table 9. Fatty Acid Composition of Egg Yolk Lipids
Fatty Acid Diet A (%) Diet B (%) Diet C (%) Diet D (%) P-value
14:0
16:0
16:1
18:0
18:1
18:2
18:3
0.06 ± 0.14 0.06 ± 0.15 0.06 ± 0.01 0.00 ± 0.00 NS
26.05 ± 1.60 24.16 ± 1.68 24.97 ± 2.48 23.81 ± 3.56 NS
2.69 ± 1.37 2.51 ± 1.32 2.65 ± 1.33 3.12 ± 0.27 NS
9.92 ± 0.61 9.19 ± 0.48 9.24 ± 0.69 8.95 ± 1.38 NS
40.94 ± 3.18 38.84 ± 3.05 40.14 ± 2.79 38.60 ± 1.60 NS
14.23 ± 1.18 14.09 ± 1.09 14.18 ± 1.38 13.62 ± 1.60 NS
0.09 ± 0.22 0.00 ± 0.00 0.13 ± 0.31 0.18 ± 0.44 NS
FAME analysis of egg oil samples from collection day 10.
Diets are A=no supplements, B enriched with 0.012% tocomin and 0.49% algae biomass; C 
enriched with 0.036% tocomin and 1.47% algae biomass; and D enriched with 0.072% 
tocomin and 2.94% algae biomass.
Values are mean ± standard deviation.
*P-value NS - not significant.
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Table 10. Phospholipid Composition of Egg Yolk Lipid as Determined by 31P NMR
Phospholipids Diet A 
(weight %)
Diet B 
(weight %)
Diet C 
(weight %)
Diet D 
(weight %)
P-value
CL
PE
SM
LPC
PI
PC
Total in oil
1.22 ± 1.36 0.36 ± 0.88 1.32 ± 1.46 0.83 ± 1.29 NS
19.86 ± 0.73 19.09 ± 1.22 19.62 ± 1.58 18.37 ± 1.62 NS
1.75 ± 0.27 1.57 ± 0.28 1.56 ± 0.53 1.72 ± 0.23 NS
0.04 ± 0.09 0.04 ±0.11 0.08 ± 0.20 0.00 ±0.00 NS
1.73 ± 0.17 0.84 ± 0.95 1.66 ± 0.25 1.39 ± 0.70 NS
75.40 ± 0.60 78.10 ± 2.11 75.75 ± 2.20 77.69 ± 1.83 NS
31.18 ± 0.79 29.15 ± 4.19 28.30 ± 4.94 30.61 ± 2.32 NS
Phospholipid composition analysis of egg oil samples from collection day 10. CL-
cardiolipin, PE-phosphatidylethanolamine, SM-sphingomyelin, LPC-lysophophatidylcholine, 
PI-phosphatidylinositol, PC-phosphatidylcholine.
Diets are A=no supplements, B enriched with 0.012% tocomin and 0.49% algae biomass; C 
enriched with 0.036% tocomin and 1.47% algae biomass; and D enriched with 0.072% 
tocomin and 2.94% algae biomass.
Values are means ± standard deviation.
*P-value NS - not significant.
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Table 11. Nutrient Transfer Efficiency to Egg Yolk (%)
Day Component Diet B Diet C Diet D P-value
8 or 
10
35
56
α-Tocopherol 9.90 ± 1.85 a 3.83 ± 1.30 b 3.43 ± 0.95 ab *
α-Tocotrienol 1.72 ± 0.20 a 1.39 ± 0.12 b 1.41 ± 0.15 b *
β-Tocotrienol 0.52 ± 0.60 a 0.75 ± 0.05 b 0.72 ± 0.10 b **
γ-Tocotrienol 0.16 ± 0.02 a 0.13 ± 0.01 ab 0.13 ± 0.02 b *
δ-Tocotrienol 0.00 ± 0.00 a 0.06 ± 0.02 b 0.05 ± 0.01 c **
Astaxanthin 14.89 ± 2.20 a 10.59 ± 1.83 b 7.60 ± 1.26 c *
α-Tocopherol 3.95 ± 2.18 a -0.27 ± 1.30 b -0.19 ± 0.76 b **
α-Tocotrienol 0.89 ± 0.13 a 0.45 ± 0.24 b 0.54 ±  0.08 b **
β-Tocotrienol 0.54 ± 0.33 0.34 ± 0.17 0.46 ± 0.06 NS
γ-Tocotrienol 0.09 ± 0.01 a 0.06 ± 0.03 b 0.07 ± 0.01 b **
δ-Tocotrienol 0.00 ± 0.00 a 0.01 ± 0.02 a 0.04 ± 0.01 b **
Astaxanthin 11.95 ± 4.02 a 9.46 ± 2.25 ab 6.31 ± 1.16 b **
α-Tocopherol -1.11 ± 3.03 -1.48 ± 0.85 -0.74 ± 0.59 NS
α-Tocotrienol 0.56 ± 0.08 a 0.38 ± 0.07 b 0.36 ± 0.73 b **
β-Tocotrienol 0.00 ± 0.00 a 0.30 ± 0.07 b 0.31 ± 0.07 b **
γ-Tocotrienol 0.05 ± 0.01 0.05 ± 0.01 0.04  ± 0.01 NS
δ-Tocotrienol 0.00 ± 0.00 a 0.00 ± 0.00 a 0.02 ± 0.01 b **
Astaxanthin 9.26 ± 1.77 a 7.08 ± 1.64 b 5.12 ± 1.02 c **
Feeding transfer resulting in egg yolks at maximum amount on day 8 values for all tocos, and 
day 10 for astaxanthin.  
Diets are A=no supplements, B enriched with 0.012% tocomin and 0.49% algae biomass; C 
enriched with 0.036% tocomin and 1.47% algae biomass; and D enriched with 0.072% 
tocomin and 2.94% algae biomass.
Values are means ± standard deviation.  
*P-value ≤ 0.05; **P-value ≤ 0.01.
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Table 12. Kinetics Parameters of Hen Feed Using Arrhenius Approach
Component Apparent 
Order
Activation 
Energy 
(kJ/mol)
ln(A) R2 k (day-1) 
at 25 °C
t1/2 (days) 
at 25 °C
α-Tocopherol
α-Tocotrienol
β-Tocopherol
β-Tocotrienol
γ-Tocopherol
γ-Tocotrienol
δ-Tocopherol
δ-Tocotrienol
Astaxanthin
First 28.8 7.05 0.4936 1.0 x 10-2 67.5
First 307.6 7.70 0.6958 1.3 x 10-2 53.9
Second 48.5 11.91 0.7549 4.8 x 10-4 72.8
Second 29.5 4.22 0.9656 4.5 x 10-4 23.1
Zero 36.7 14.11 0.8057 5.0 x 10-1 0.3
Second 49.0 10.01 0.8162 5.9 x 10-5 39.5
First 48.8 13.76 0.663 2.7 x 10-3 254.6
Second 50.9 10.31 0.9071 3.6 x 10-5 56.5
Second 106.7 28.37 0.9607 4.2 x 10-7 307.1
Results of HPLC for tocotrienol, tocopherol, and astaxanthin analysis of highest diet level by 
determining the apparent order, activation energy, k value, and half-life value.  The highest 
concentration diet was used for the experiment.
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Figure 1. Descriptive sensory panel ballot  developed during panelist training sessions and 
used for evaluation of hard-boiled eggs.  The line scale is 15-cm unstructured for each 
descriptor.
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Figure 2. Feed samples after mixing the diets.  The diets are as follows: D (0.072% tocomin 
and 2.94% algae biomass), C (0.036% tocomin and 1.47% algae biomass), B (0.012% 
tocomin and 0.49% algae biomass) and A (control) as seen from left to right.
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Figure 3. Color change of egg yolks from day  0 of study through day 56 for fresh egg yolk 
samples.  Open symbols are a* values and closed symbols are b* values.  Standard deviation 
bars are shown in all charts have the mean and standard deviation bars. Diets are A=no 
supplements, B enriched with 0.012% tocomin and 0.49% algae biomass; C enriched with 
0.036% tocomin and 1.47% algae biomass; and D enriched with 0.072% tocomin and 2.94% 
algae biomass.
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Figure 6. HPLC quantification of tocotrienols and tocopherols over the 56 day feeding 
period, showing means and standard deviations from 6 replicates. Diets are A=no 
supplements, B enriched with 0.012% tocomin and 0.49% algae biomass; C enriched with 
0.036% tocomin and 1.47% algae biomass; and D enriched with 0.072% tocomin and 2.94% 
algae biomass.
93
0
0.4
0.8
1.2
1.6
2.0
β-
to
co
tri
en
ol
 (p
pm
 in
 o
il)
0
1
2
3
4
5
γ-
to
co
tri
en
ol
 (p
pm
 in
 o
il)
A B
C D
0
26
52
78
104
130
α-
to
co
ph
er
ol
 (p
pm
 in
 o
il) A B
C D
0
6
12
18
24
30
α-
to
co
tri
en
ol
 (p
pm
 in
 o
il) A B
C D
0
0.6
1.2
1.8
2.4
3.0
β-
to
co
ph
er
ol
 (p
pm
 in
 o
il) A B
C D
A B
C D
0
1.4
2.8
4.2
5.6
7.0
0 6 12 18 24 30 36 42 48 54 60
δ-
to
co
ph
er
ol
 (p
pm
 in
 o
il)
Time (days)
A B
C D
0
0.12
0.24
0.36
0.48
0.60
0 6 12 18 24 30 36 42 48 54 60
δ-
to
co
tri
en
ol
 (p
pm
 in
 o
il)
Time (days)
A B
C D
0
10
20
30
40
50
γ-
to
co
ph
er
ol
 (p
pm
 in
 o
il) A B
C D
Figure 7. HPLC of astaxanthin quantification over the 56 day feeding period, showing 
means and standard deviations from 6 replicates.  Diets are A=no supplements, B enriched 
with 0.012% tocomin and 0.49% algae biomass; C enriched with 0.036% tocomin and 1.47% 
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CHAPTER 4. LITERATURE REVIEW-ARTIFICIAL OIL BODY
GENERAL INTRODUCTION
  Oil naturally occurs in plant cells, pollen, spores, and seeds where lipid can be stored 
in sub-cellular lipid particles, oil bodies (Frandsen et  al., 2001; Huang, 1994).  Oil bodies can 
be found in seeds and pollen of angiosperms and primitive plants, like gymnosperms and fern 
spores (Jiang et al., 2009).  Lipid particles are found in mammal tissues, eggs of some 
nematodes, yeast, or algae (Huang, 1994).  The particles have been called lipid bodies, oil 
bodies, oleosomes, or spherosomes (Huang, 1992). Spherosomes is an old term used to 
describe sub-cellular particles where their matrix content is uncertain (Huang, 1992).  This 
review will use oleosomes and oil bodies interchangeable when referring to naturally 
occurring structures.    This literature review will examine naturally  occurring oleosomes, 
oleosin, egg yolk protein, egg phospholipids, artificial bodies, and lipid oxidation.
NATURALLY OCCURRING OLEOSOMES
 Plant oil bodies are very stable at neutral pH values.  They  do not aggregate or 
coalesce in vivo during seed maturation or after centrifugation (Haung, 1994).  Oil bodies are 
made up of three basic components, proteins, phospholipids, and triglycerides (Huang, 1992). 
Oil bodies have a matrix composed of triacylglycerols (TAG) bond by phospholipid 
monolayer with unique proteins, oleosins, caleosins, and steroleosins (Bhatla et al., 2010; 
Frandsen et al., 2001; Huang, 1994). Oleosin and caleosin are considered to contribute to 
structural stability of oleosomes, but not steroleosin (Liu et al., 2009).  Generally, oleosomes 
in situ are spherical, yet they can be pressed into irregular shapes by other cellular structures 
(Bhatla et al., 2010).  Oil bodies are typically 0.5-2.5 µm in diameter where the size can be 
directly  affected by the nutritional status and environmental factors (Frandsen et al., 2001; 
Tzen et al., 1998).  Oil bodies have been observed from mature seeds of rape (Brassica napus 
L.), mustard (Brassica juncea L.), cotton (Gossypium hirsutum L.), flax (Linus usitatis 
simum), maize (Zea mays L.), peanut (Arachis hypogaea L.), and sesame (Sesamum indicum 
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L.) (Tzen et al., 1993).  Plants use the 
o leosomes as ene rgy sources fo r 
germination and post-germinative seedling 
growth (Tzen et al., 1998; Peng et al., 
2003). Oleosomes are held together by 
simple physical forces, steric hindrance and 
negative surface charge by oleosin (Huang, 
1992; Chiang, 2010).  Oleosomes are stable 
both in vitro and in vivo (Chiang, 2010).  It 
is generally  understood the oil body has a 
matrix of TAG surrounded by a layer of 
phospholipids embedded with alkaline 
proteins, oleosins (Figure 1) (Tzen et al., 
1998).  The phospholipids form a monolayer where the acyl moieties face inward to interact 
with the hydrophobic TAG within the matrix while the hydrophilic head groups exposed to 
the cytosol (Tzen et al., 1993).  The proteins have three structural domains, N-terminal 
amphipathic domain, central hydrophobic domain, and C-terminal amphipathic domain.  The 
hydrophobic portion penetrates the phospholipid layer into the TAG matrix and the 
hydrophilic region rest  on the phospholipid layer exposed to the cytosol (Tzen et al., 1993). 
There are minor proteins of higher molecular mass also embedded in the phospholipid 
monolayer (Chen and Tzen, 2001).  The three minor proteins termed Sops 1-3, have been 
identified in sesame oil bodies, but their functions remain unknown (Chen and Tzen, 2001). 
Five seed-specific oleosins have been identified in Arabidopsis thaliana ranging in size from 
14-21 kDa (Gohon et al., 2011).  Sop1, also known as caleosin for its calcium-biding 
capacity, is very similar to oleosin in structure, containing an N-terminal hydrophilic domain, 
central hydrophobic anchoring domain, and a C-terminal hydrophilic domain (Chen and 
Tzen, 2001).   Caleosin and oleosin are very different when examining the sequence and only 
share 26% of the sequence (Gohon et al., 2011). Oleosin S5 is the smallest at 14.9 kDa due to 
a shorter N and C termini and is the most hydrophobic oleosin (Gohon et al., 2011).  Oleosin 
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Figure 1. Schematic of oil body.  Outer layer is 
proteins with phospholipids and inside are 
triglycerides.
S3 (186 kDa) is the most abundant protein in Arabidopsis thaliana with longer N and C 
termini than S5 making the protein less hydrophobic (Gohon et al., 2011).  S5 and S3 share 
63% sequence identity (Gohon et al., 2011).
 During seed maturation, oil bodies are formed on the rough endoplasmic reticulum by 
budding TAG between the two phospholipid layers and oleosins simultaneously are 
synthesized on polyribosomes, which are bound to the endoplasmic reticulum (Frandsen et 
al., 2001; Huang, 1994).  The resulting oleosins move to the budding TAG particle where the 
hydrophobic domain guides the placement on the oil bodies (Huang, 1994; Chen and Tzen, 
2001).  Typically an oil body consists of 94-98% (w/w) neutral lipids, 0.6-2% phospholipids 
and 0.6-3% proteins (Tzen et al., 1993).  The neutral lipids are in the TAG form where the 
composition can vary greatly among different species (Tzen et al., 1993).  
 
OLEOSIN
 Oleosin is unique and principal membrane 
protein to oleosomes (Bhatla et al., 2010; 
Frandssen et al., 2001; Huang, 1994).  There are 
two isoform classes, H- and L-oleosin with the 
main difference being the insertion of 18 residues 
in the C-terminal domain in the H-oleosins (Tai et 
al., 2002).  These proteins are alkaline in nature 
with low molecular masses, 15-25 kDa (Haung, 
1992).  In typical oleosomes the oleosin account 
for approximately 1-4% of the total weight 
(Huang, 1992). The protein has a tripartite 
structure with a hydrophobic domain of 70 
residues located at the center which interacts with 
the oils in the oleosome is highly conserved among species including sesame, Arabidopsis 
thaliana, maize and rice within the same isoform class (Tai et al., 2002; Liu, 2009).  A 
proline knot motif lies in the center of the hydrophobic region of three prolines within a 12-
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Figure 2. Schematic of oleosin protein on the 
surface of oil body. Figure adapted from 
Huang, 1994.
residue sequence taking the secondary structure of two β-strands in antiparallel formation 
(Abell et al., 2004; Huang, 1994; Tzen et al., 1998).  The proline knot is the section of the 
protein that is inserted into the oil body  TAG matrix like a hairpin (Frandsen et  al., 2001). 
The proline knot has also been suggested to play an essential role to target oil bodies (Chen 
and Tzen, 2001).  The N- and C-termini are two hydrophilic domains with secondary 
structure of α-helix that reside on the oil body surface (Abell et al., 2004; Frandsen et  al., 
2001).  These domains can vary among oleosins from different species (Huang, 1994). 
Oleosin is synthesized in the endoplasmic reticulum membrane both in vitro and in planta 
(Abell et al., 2004).  Literature suggests oleosin may be synthesized on specific TAG-
synthesizing subdomains (Abell et al., 2004).  TAG accumulates between the endoplasmic 
reticulum phospholipid bilayer to produce droplets (Frandsen et al., 2001).  O l e o s i n 
exists in two distinct oleosin isoforms, molecular mass of 18 and 16 kDa as found in rice but 
can range from 15-26 kDa depending on the isoform and plant species (Tzen et  al., 1998). 
The central hydrophobic region is highly conserved among species (Tzen et al., 1998).
 Oleosin functions as a shield of the phospholipids and stabilize to the oil bodies 
(Frandsen et  al., 2001).  The topology of oleosin exposed to the cytosol gives the oil bodies a 
negatively charged surface which helps to prevent aggregation and coalescence (Tzen et al., 
1993).  The surface charge can be changed, by  lowing the pH, will result  in a neutral oil body 
surface causing aggregation (Frandsen et al., 2001).  Oleosins are only required for long-term 
storage as oleosins are not found in olives and avocados.  The oil bodies in these examples 
are not long-term storage organelles (Frandsen et al., 2001).  The relative size of the oil 
bodies can be controlled by the ratio of oil to oleosin.  Maize kernels with high oil content 
have high ratio oil to oleosin will have large oleosomes, while low-oil breeds with a low ratio 
will have smaller oil bodies and irregular surfaces (Frandsen et al., 2001).   
EGG YOLK PROTEINS
  Egg yolk poteins have a range of functional properties.  Yolk proteins are 
present in free and apoproteins.  On a basis of dry matter, yolk has five major protein 
constituents which are as follows: 68% low-density lipoproteins (LDL) or also known as 
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lipovitellins, 16% high-density lipoproteins (HDL), 10% globular proteins (livetins), 4% 
phosphoproteins (phosvitins), and 2% minor proteins (Huopalahti et al., 2007; Aluko and 
Mine, 1998; Aton el al., 2003; Jolivet et al., 2006).  Low density lipoproteins are the main 
constituent in egg yolk making up  approximately two-thirds of the dry material made of 87% 
lipids and 12% proteins (Huopalahti et  al., 2007; Aton et al., 2003).  These proteins are 
similar to the lipoproteins found in chicken blood when the blood enters the ovaries, the 
lipoproteins are transferred to the yolk (Huopalahti et al., 2007; Jolivet et al., 2006). 
Described to be a polypeptide chain folded in a globular configuration, these proteins form 
spherical particles with the lipid molecule within the protein and a variable amount of lipid 
on the surface (Aluko and Mine, 1998; Aton et al., 2003; Jolivet et al., 2006).  High-density 
lipoproteins are the second group, accounting for one-sixth of the dry yolk matter and 36% of 
the protein (Huopalahti et al., 2007).  These proteins are made up of 75-80% proteins and 
20-25% lipids (Huopalahti et al., 2007).  The lipids are composed of 65% phospholipids, 
30% triglycerides, and 5% cholesterol (Huopalahti et al., 2007).  The third group are 
phosphoglycoproteins called phosvitins. Of the known proteins for this group, 50% of the 
amino acids are serine and of which, 90% is phosphorylated (Huopalahti et al., 2007).  Due 
to the unique chemical characteristics, phosvitins act as phospholipid antioxidants 
(Huopalahti et al., 2007).  The last group of proteins are the globular proteins also known as 
livetins.  These proteins have different fractions including α-, β-, and γ-livetin at the ratio of 
2:5:3, respectively.
 Dyer-Hurdon and Nnanna (1993) found proteins that exist in the plasma, low-density 
lipoproteins and livetins, had better emulsifying activity and stability  at low ionic strength, 
<0.3 M sodium chloride. Its been reported that protein emulsifying properties are due to the 
large range of proteins and experimental conditions (Anton et al., 2003).  A study  completed 
by Anton and Gandemer (1997) fractioned yolk into granules and plasma and found there 
was no difference when emulsions were made with yolk, granules, or plasma. They  also 
noted the contribution of proteins to the emulsifying activity was higher than phospholipids. 
At 80% solubilization, Anton and Gandemer (1997) noted the granules formed a more stable 
emulsion than yolk or plasma due to the composition of granules.  Granules contained half 
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the lipids and cholesterol and double the proteins as compared to yolk and plasma (Anton 
and Gandemer, 1997).
EGG PHOSPHOLIPIDS
 Of the total lipids in egg yolk, approximately 30% are phospholipids and often 
referred as egg yolk lecithin (Stadelman and Cotterill, 1995).  There are several compounds 
that make up phospholipids including two main compounds, phosphatidylcholine (PC, 76%) 
and phosphatidylethanolamine (PE, 22%) (Aluko and Mine, 1998).  Lysophospholipid (LPC, 
3-6%), sphingomyelin (SM, 3-6%), and phosphatidylinositol (PI, 0.6%) are also found in egg 
yolk phospholipids as minor components (Rhodes and Lea, 1957).  Phospholipids are used as 
emulsifiers in food products and industry applications.  Phospholipids coat oil droplets 
therefore reduce the surface tension between the immiscible phases.  There are various forces 
stabilizing the oil-in-water emulsion, such as Van der Waals force, steric interaction, 
electrostatic force, hydration interaction, and hydrophobic interaction (Levine et al., 1989).
ARTIFICIAL OIL BODIES
 The natural oleosomes contain oil surrounded by a membrane of phospholipids or 
lecithin and a layer of hydrophobic proteins, usually oleosin.  It  is mechanically feasible for 
artificial oil body  formation using the three essential components, neutral lipids (TAGs) 
94-98%, phospholipids 0.5-2%, and proteins 0.5-3.5% (Peng et al., 2007).  The use of egg 
lecithin is growing as a food product in industry primary  as emulsifiers.  With the increased 
demand of lecithin, the abundance of by-product, yolk protein, is also increasing.  Yolk 
protein contains high nutritional value and may also have the property  to form artificial oil 
bodies, which this research will explore.  Egg yolk proteins are low and high density 
lipoproteins within the yolk.  With the addition of yolk protein and lecithin, a protective outer 
monolayer will form highly oxidizabable omega-3 oils.  The success of this study may lead 
to new applications for egg yolk proteins to produce artificial oil bodies where the lipid core 
can be protected from oxidation.
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LIPID OXIDATION
 Lipid oxidation is a great concern for industry producing lipid-containing foods. 
Oxidation not only produces offensive odors and flavors but also decrease nutritional value. 
Oxidation can be initiated by  autoxidation, photoxidation, or enzyme catalyzed reaction. 
Typically lipid oxidation occurs by autoxidation since the oxidation rate increases as the 
reaction continues (Fennema, 1976). Other mechanisms can occur if the oxidants or enzyme 
control the oxidation.  Free-radical oxidation mechanism involves three stages: initiation, 
propagation, and termination.  Autoxidation occurs when oxygen reacts with organic 
substrates (RH) to yield hydroperoxides (Fennema, 1976; Halliwell and Chirico, 1993). In 
the first stage, initiation, the hydrocarbon losses a hydrogen forming a radical.  If oxygen is 
present in the system the oxygen will add to a double bond forming a peroxyl radical 
(Fennema, 1976; Halliwell and Chirico, 1993).  The initiation step  will produce two free 
radicals (Fennema, 1976).  The susceptibility  of the substrate depends on the relative ease to 
donate a hydrogen. With natural lipids there are often double bonds where the availability  of 
allylic hydrogens will dictate oxidation. The more double bonds, like PUFAs, in a fatty acid 
chain, the easier for radical to form (Halliwell and Chirico, 1993).  Peroxyl radicals can 
combine if they meet, attack membrane proteins, or obtain a hydrogen from an adjacent fatty 
acid chain propagating the reaction (Halliwell and Chirico, 1993).  Oxidation can be initiated 
by different molecules.  Reactive OH˙ can be formed by  high-energy irradiation in solution 
or by transition-metal salts reacting with H2O2 to form OH˙ (Halliwell and Chirico, 1993).  In 
lipid oxidations studies, copper and iron ions are used to stimulate oxidation.  Singlet oxygen 
is another way to generate lipid peroxides by singlet O2 interaction directly with the fatty 
acid (Halliwell and Chirico, 1993; Frankel, 1980). Singlet  oxygen can be generated many 
ways, yet one important way is by light exposure (Frankel, 1980). Propagation continues the 
reaction to form peroxy radicals, hydroperoxides, and new hydrocarbon radicals (Fennema, 
1976). Propagation length can depend on many factors including the lipid-protein ratio, fatty 
acid composition, oxygen concentration, and the presence of antioxidants (Halliwell and 
Chirico, 1993).  If two radicals interact or if an antioxidant is present, termination occurs.
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 Hydroperoxides can be decomposed by high-energy  radiation, thermal energy, metal 
catalysis, or enzyme activity (Fennema, 1976).  The first step of decomposition in an 
unsaturated hydroperoxide is the homolytic cleavage of the oxygen-oxygen bond to yield 
alkoxy  and hydroxy radical (Frankel, 1980).  Carbon-carbon bonds are cleaved to result in 
aldehyde esters and aldehydes (Frankel, 1980).  Decomposition of hydroperoxides will result 
in the formation of additional radicals which can start oxidation initiation events (Fennema, 
1976).  Decomposed hydroperoxides result in several secondary products including 
aldehydes, alcohols, and acids (Fennema, 1976) causing rancid flavor.
 Lipid oxidation can be measured by loss of unsaturated fatty  acids, primary product 
quantification, or secondary product quantification.  HPLC or GC methods can be used to 
measure not only the loss of unsaturated fatty acids but also to identify the product 
distributions (Halliwell and Chirico, 1993).  Other methods for lipid peroxides quantification 
include glutathione peroxidase, cyclooxygenase, and iodine liberation.  Secondary  products 
are most commonly measured by 2-thiobarbituric acid-reactive substances because its simply 
and inexpensive (Halliwell and Chirico, 1993).
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CHAPTER 5. A NOVEL USE OF EGG YOLK PROTEIN AND 
LECITHIN IN THE FORMATION OF ARTIFICIAL OIL BODIES FOR 
STABILIZING OMEGA-3 OIL
Laurie Walker1 and Tong Wang1, 2
ABSTRACT
 Egg yolk protein is a co-product from egg lecithin isolation.  We hypothesize egg 
yolk protein and egg lecithin can be used to make artificial oil bodies (AOB) mimicking the 
naturally  occurring oleosomes with similar stability and oil protection from oxidation.  Egg 
yolk protein, soy protein isolate, and naturally occurring oleosomes were used for a 30-day 
oxidation study.  Egg yolk protein and soy  oleosin were also used for a 2-week accelerated 
oxidation test with fish oil to determine the effect of environment (pH 3 and 7) and in the 
presence of a pro-oxidant (0 and 50 ppm CuSO4) on lipid oxidation.  Both experiments were 
evaluated for primary oxidation (peroxide value), secondary oxidation TBARS (2-
thiobarbituric acid-reactive substances), particle size, and turbidity. Native soy oleosomes 
had lowest primary and secondary oil oxidation.  Yolk protein created more stable AOB than 
soy  protein isolate.  All three oil bodies were not significantly different for turbidity.   pH and 
pro-oxidant had effects on the particle size and turbidity of the accelerated 2-week oxidation, 
but was unable to determine statistical significance because the AOB were not stable and oil 
was separated from the system.
Key words: Artificial oil body, egg yolk protein, oleosome, oleosin
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INTRODUCTION
 Lipid oxidation and the generation of secondary  oxidation products have been a 
serious concern for food industry  in terms relating to food quality  and consumer health. 
Lipids with higher unsaturation are easier for oxidation.  Several studies illustrate linoleic 
acid oxidation was 20-40 times faster than oleic acid (Kolakowska, 2003; Frankel, 1980; 
Fatemi and Hammond, 1980).  Polyunsaturated fatty  acids (PUFAs) are a significant amount 
of total lipid due to their natural occurrence and presence in fortified formulations, so they 
present more challenges for oxidation prevention.  Other factors can influence the rate of 
oxidation, such as transition metal ions commonly found in food emulsions like copper and 
iron, can initiate or accelerate oil oxidation (Wang and Wang, 2008).  Copper is less likely to 
be found in food but has been shown to be more active accelerating primary oxidation 
product decomposition (Yoshida, 1992).  Other factors, such as oxygen availability, storage 
temperature, and pH can also affect oxidation rate (Wang and Wang, 2008).  
 Oil bodies, or oleosomes, is nature’s way to protect lipids from oxidation.  Oil bodies 
are made up of three basic components, proteins (1-4%), phospholipids (1-4%), and 
triglycerides (92-98%) (Huang, 1992). Oil bodies have a matrix comprised of triacylglycerols 
bound by phospholipid monolayer mixed with unique proteins, oleosins, caleosins, and 
steroleosins (Bhatla et al., 2010; Frandsen et al., 2001; Huang, 1994). Oleosin and caleosin 
are considered to contribute to structural stability of oleosomes, but not steroleosin (Liu et 
al., 2009).  Generally, oleosomes in situ are spherical, yet they can be pressed into irregular 
shapes by  other cellular structures (Bhatla et al., 2010).  Oil bodies are typically 0.5-2.5 µm 
in diameter where the size can be directly  affected by the nutritional status and environmental 
factors (Frandsen et  al., 2001; Tzen et al., 1998).  Oleosomes from E. plantagineum were the 
most stable form of dispersed oil, even more so than bulk oil extracted after incubating at 40 
°C for one week (Gray  et al., 2010).  Although oil body  suspension can become unstable and 
aggregate over a pH range of 4-6 and salt concentrations greater than 25 mM (Chen et al., 
2010), oleosomes are in general, stable both in vitro and in vivo (Chiang, 2010).
 Artificial oil bodies (AOB) can serve as carriers for hydrophobic molecules like 
neutraceuticals, pharmaceutical drugs, probiotics, or healthy fatty acids like omega-3 (Chen 
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et al., 2004; Peng et al., 2003; Chiang, 2010).  Hen egg yolk is marketed as low value product 
(Anton and Gandemer, 1997) and its protein may be an ideal candidate for making AOB. 
The proteins in egg yolk typically are hydrophilic, but also contain hydrophobic groups that 
can be absorbed into oil-water interface (Daimer and Kulozik, 2010).  Egg yolk proteins can 
provide stabilizing effects in food systems with low pH (Nilsson et al., 2007). For this study, 
egg yolk protein, yolk lecithin, and soybean oil were used to make AOB with a ratio that is 
naturally  occurring in soybean oleosomes.  Egg lecithin was used since it contains less 
linoleic and almost no linolenic acid as compared to soy lecithin (Wang and Wang, 2008). 
Egg lecithin contains mainly  phosphatidylethanolamine (PE, 18.1%) and phosphatidylcholine 
(PC, 78.7%) (Wang and Wang, 2008).
 With the ease of PUFAs oxidation, it is the goal of this study is to create AOB to 
mimic naturally occurring oleosomes to protect the encapsulated oil from oxidation. We 
hypothesize the artificial oil bodies created with egg yolk protein and phospholipids will 
have an increased stability compared with that prepared from other types of protein.
MATERIALS AND METHODS
Starting Material Preparation
 Soy Protein Isolate. Soy  protein isolate (SPI) (90.89% protein) was obtained from 
ADM (Lot #10013011, 2010, USA). 
 Defatting of Egg Yolk Proteins. Full-fat spray-dried egg yolk material was obtained 
from Rembrandt Enterprises (Rembrant, IA).  Ten grams of the egg yolk powder was mixed 
with 10 mL of hexanes and placed into a column (1.5 cm wide x 16 cm long) with silica gel 
at the bottom of the column.  The top of the column was covered with aluminum foil to avoid 
evaporation of the hexanes.  Fractions were collected for each additional 10 mL of hexane 
added to the top  of the column.  Hexanes were allowed to run through the column under the 
force of gravity.  Once the fractions of oil had been collected, the yolk proteins (67.13% 
protein) were left  in the fume hood to dry and then placed in the vacuum oven overnight  to 
remove hexanes completely at ambient temperature.
109
 Soybean Oleosome Extraction and Purification.  Oleosomes were obtained from 
dehulled, full-fat soybean flour (2008 crop year) from Natural Products Inc. (Grinnell, IA). 
The method was modified from Kapchie et al. (2011) from a pilot-plant scale to a lab bench 
scale.  Soy flour of 25 grams were mixed 150 mL with 0.1 M potassium acetate pH 4.6 
containing 0.5 M  sodium chloride and 0.4 M sucrose.  Enzymes of 3% (vol/wt) (Multifect® 
Pectinase FE, Multifect® GC, Multifect® CX B) from Genencor International (Rochester, 
NY) was used.  Multifect® Pectinase FE from Aspergillus niger is reported to contain 
pectinase, cellulase and hemicellulase activities (145 – 180 U/g);  Multifect® CX B is a β-
glucanase derived from a selected strain of Trichoderma reesei, with activity of 2,250 BGLU/
mL (β-glucanase unit per milliliter);  Multifect® GC from Trichoderma reesei is a cellulase 
with a minimum activity of 82 GCU/g (Kapchie et al., 2011).  The extraction mixture was 
incubated at  57 ºC overnight with a constant stirring at 35 rpm (shaker model 3582, Thermo 
Scientific, USA).  After incubation, the mixture was mixed using a single speed blender 
(Model 700G, Waring Commercial, USA) for three minutes.  The mixture was then 
centrifuged at 3,000 g for 45 minutes.  The fat pad was removed from the top of the 
supernatant and pellet.  The fat pad was resuspended in 0.1 M  tris hydrochloric acid pH 8.6 
containing 0.4 M sucrose and 0.5 M  sodium chloride by mixing with a stir bar until no 
clumps were present.  The resuspended oleosomes were centrifuged at  3,000 g for 45 minutes 
and separated from the supernatant and pellet, and the procedure was repeated until no pellet 
formed after centrifugation.  
 The oleosomes were then purified by adapting the methods of Kapchie et  al. (2011) 
and Kapchie et al. (2008).  The unpurified oleosomes were weighed and washing solution of 
0.1 M Tris hydrochloric acid, 0.4 M  sucrose, and 0.5 M sodium chloride at pH 8.6 was added 
at a ratio of 1:10 (oleosomes:washing solution).  The mixture was centrifuged at 10,000 g, 4 
ºC, for 30 minutes (Avanti® J-20 Series, Beckman Instruments Inc., Fullerton, CA). 
Oleosomes floating on the top were collected and resuspended in the same amount of 
washing solution.  A total of three wash cycles were carried out.  The final washed oleosomes 
underwent dialysis in 10 mM  sodium phosphate buffer, pH 7.0, to remove the remaining salt 
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and sugar from the oleosome dispersion overnight with periodic changing of the water in the 
1 L beaker. 
 Oleosin Extraction.  The oleosomes were freeze-dried before hexane extraction.  Ten 
grams of the freeze-dried oleosomes was mixed with 10 mL of hexanes.  Oleosin was 
extracted from the washed and purified oleosomes in a similar manner to the method 
mentioned for egg yolk protein extraction.  The dispersion of oleosomes and hexanes was 
filled in the glass column and extracted for a total of eight times.  The defatted material was 
dried in a vacuum oven overnight at ambient temperature, to remove remaining hexanes.  
Oxidation Study 
 Stability of Natural Soy Oleosome and Artificial Oil Bodies Created by Using Egg 
Yolk Protein and Soy Protein Isolate. Oleosomes were placed into 50 mL erlenmeyer flasks 
at the same concentration as the AOB created with egg yolk protein and the SPI.  The AOBs 
were created by using a method according to Tzen et  al. (1998) and Chen et al. (2005).  The 
40 mL suspension contained 18 g of soybean oil extracted from oleosomes, 0.18 g of egg 
lecithin, and 0.27 g of protein (dwb), either egg yolk protein or SPI.  The liquid for the 
suspension was 10 mM sodium phosphate buffer, pH 7.0.  Egg yolk protein or SPI, egg 
lecithin, and buffer were first added to the a 50 mL conical centrifuge tube and sonicated 
(Sonicator XL2020, Misonix Inc. Farmingdale, NY) for 1 minute at 20 second intervals with 
30 seconds rest in between sonication cycles at an amplitude of 35% using a flat tip (0.5 inch 
diameter).  Samples were placed in an ice-water bath to dissipate heat during sonication.  The 
use of the sonicator is to break up  large protein particles so that the smaller particles may 
expose hydrophobic groups allowing for the more interaction on the oil-water interface 
(Diamer and Kulozik, 2010).  Soybean oil extracted from oleosomes was added to mixture 
and sonicated again in the same manner.  Samples were then transferred to 50 mL erlenmeyer 
flasks.   All flasks were covered with aluminum foil with small holes punched and were 
placed into an oven at 55 ºC (FED 53, forced convection, Binder Inc, NY) for 30 days.  Each 
day throughout the study buffer was added to equal the amount of evaporation (typically 0.5 
g) over the past  24 hours.  Samples were shaken by hand to homogenize the sample each day 
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after added back evaporated buffer, unless there was noticeable oil where the samples were 
sonicated for 20 seconds to incorporate the oil back into the AOB system.  A flask of soybean 
oil, bulk oil system, was used a control.  Each treatment was completed in duplicate.
 Effect of AOB Protein and Environment on Fish Oil Oxidation.  Egg yolk protein 
and the extracted oleosin protein were used for this experiment.  Both proteins were used 
with the same ratio relative to lecithin and oil as for above except fish oil was used.  There 
were four environment treatments in 10 mM sodium phosphate buffer, 0 ppm CuSO4 pH 7, 
50 ppm CuSO4 pH 7, 0 ppm CuSO4 pH 3, or 50 ppm CuSO4 pH 3.  A flask of fish oil, bulk 
oil system, was used a control.  Each treatment was completed in duplicate.
Evaluation Analysis
 Images of samples.  Light microscopy  images were taken every 3 days for the 
soybean oil experiment and every 2 days for the fish oil experiment to monitor the changes 
under 100x magnification.  
 Turbidity Test.  A 1 mL sample was taken from each treatment and used for turbidity 
test after the initial sonication, according to a method of Tzen et al. (1998).  The mixture was 
placed in a disposable cuvette of 1.8 mL capacity.  Dilutions were made with 10 mM  sodium 
phosphate buffer, pH 7 or 3 depending on the sample’s environment so the sample had 
absorbance below 0.9.  The sample was subjected to minimal disturbance and measured with 
a spectrophotometer (DU 720 UV/Vis, Beckman Coulter) set at 600 nm with readings taken 
every  5 minutes for 3 hours.  The starting measurement was denoted as Ao and the time 
specific readings as A.  The relative turbidity was expressed as (Tzen et al., 1998):
T/To=10A/10Ao
 Particle Size.  Two mL sample was taken from each treatment and used for this test 
after the initial sonication.  A particle size analyzer (Mastersizer 2000 S, Malvern Inc., 
Worcestershire, United Kingdom) was used to determine particle size distribution of the 
oleosomes and AOBs.  The sample was suspended in approximately 800 mL of DI water in a 
Hydro 2000 MU (A) at 2,040 rpm.  Five readings were averaged to give a result.  Each 
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sample was measured twice.  The particle size distributions were calculated using a refractive 
index of 1.46. The laser obscuration was approximately 12-14%.
 Lipid Hydroperoxide Determination by Iron Oxidation Test. This method was 
adopted from Stine et al. (1953).  From each treatment, 1.5 mL uniform sample was removed 
and placed into a glass vial with 6 mL of 2:1 chloroform:methanol to extract the oil.  Store 
bought vegetable oil (Canola oil) was oxidized by heating, weighed, and used to calculate 
peroxide value as determined by the iodiometric method (AOCS method Cd 8-53).  This oil 
was also measured by  the iron oxidation test to establish a standard curve for PV.  Samples 
were stored at -20 °C until analyzed.   A small amount of oil sample was obtained, 10-300 
mg accurately  weighed, was placed into a 10 mL volumetric flask and filled with 2:1 
chloroform:methanol (v/v) and swirled until well mixed then filled to 10 mL.  Ammonium 
thiocyanate solution (30% w/v) of 60 µL was added to a10 mL volumetric flask and then 60 
µL of ferrous chloride (~0.014 M) was added to the flask and timed for 10 minutes before 
reading on the spectrophotometer at 515 nm (DU 720 UV/Vis, Beckman Coulter).  The 
solution was shaken periodically.  The standard curve using canola oil was diluted using 2:1 
chloroform:methanol (v/v) to several concentrations.  These solutions were placed into 10 
mL volumetric flask and followed the rest of the procedure as for the samples.
 Secondary Oxidation Products. A method used to determine the amount of 2-
thiobarbituric acid-reactive substances (TBARS) from Wang and Wang (2008) was used. 
Briefly, 15% (w/v) trichloracetic acid (TCA) and 0.375% (w/v) thiobarbituric acid (TBA) 
were dissolved in 0.25 M hydrochloric acid aqueous solution by mild heating and agitation. 
Butylated hydroxytoluene (BHT), 3 mL of 2% in absolute ethanol, was added to 100 mL of 
the TCA/TBA stock solution.  An oil sample of approximately 400 µL was accurately 
weighted and placed in a test tube and 4 mL of TCA/TBA solution was added and mixed 
thoroughly  with a Vortex mixer.  The samples were placed in a boing water bath for 15 
minutes and allowed to cool to room temperature.  Absorption was measured at 535 nm with 
a blank containing only the TCA/TBA reagent and mineral oil.  Concentrations of TBARS 
were determined using a standard curve prepared using 1,1,3,3-tetraethoxypropane ranging 
from 0 to 4.2 nmol/mL. 
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Solubility Curve 
 The oleosin and egg yolk proteins’ solubility  behavior was measured.  The protein 
was dispersed in water with a concentration of 0.75%.  Samples were placed on a magnetic 
stirrer (250 rpm) for 30 minutes for full protein suspension before 1 mL samples were taken 
from the solution.  pH was adjusted by adding either 2 N NaOH or 2 N HCl.  Samples were 
allowed to equilibrate for 30 minutes.  Removal of 1 mL sample, pH adjustment, and 30 
minute equilibration time was repeated until all pH values were taken ranging from 1-13 with 
increase or decrease of 1 pH intervals.  Samples were centrifuged for 10 minutes at 10,000 x 
g.  Supernatants were evaluated for soluble protein by using the Lowry method (Lowry et al., 
1951).  Briefly, samples were placed into tubes and 200 µL of 1 N NaOH was added along 
with 2 mL of Lowry solution, 100:1:1 of 2% sodium carbonate: 2% sodium potassium: 1% 
copper sulfate.  Samples were vortexed and allowed to stand at room temperature for 10 
minutes.  Folin-Ciocalteu phenol reagent solution (1N) of 200 µL was added to the samples, 
vortexed, and allow to stand at room temperature for 30 minutes in the dark.  Samples were 
then read on a spectrophotometer at 750 nm.  Standard protein of bovine serum albumin was 
used for standard curve development with concentration range from 0 to 0.05 mg/mL.  The 
experiment was done in duplicate. 
Statistical Analysis
 Statistical analysis was completed using SAS (version 9.2, SAS Institute Inc., Cary, 
NC) One-way analysis of variance (ANOVA) was used for mean comparisons, and Fisher’s 
least significant differences were calculated at P< 0.05 (LSD0.05).  
RESULTS AND DISCUSSION
Defatting of Egg Yolk Proteins
 Egg yolk proteins were extracted with hexanes to remove the lipids.  The results of 
the amount of oil in each extraction step are seen in Figure 1.  The amount of oil extracted 
during the 1st fraction had most of the oil, 70.7%.  As the fractions progress there was a 
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significant decrease in oil content.  In the last fractions, there was 0.0% of total oil, indicating 
a complete oil removal.  
Stability of natural soy oleosomes and AOB created by egg yolk protein and SPI  
 At the start of the experiment, all samples appeared visually the same.  All emulsions 
were a creamy fully-dispersed systems with no visual free soybean oil similar to the samples 
created by Chen et al. (2005) using caleosin to encapsulate cyclosporine A.  By the end of 30 
days, our samples had greatly  changed.  There was free soy oil apparent in all samples except 
for oleosomes.  The egg yolk protein emulsion broke at day 28 where a clear lower water 
layer and an oily  layer were observed.  SPI emulsion broke at day 23 when similar separation 
was observed.  Therefore, although yolk protein did not create a stable AOB as the 
oleosomes, it performed better than SPI.
 Turbidity Test.  The turbidity measures the stability of the dispersion.  All samples 
were not significantly different when comparing the slope (Figure 2).  This result illustrates 
egg yolk protein and SPI under these experimental conditions and over three hours did not 
lose emulsion stability.  The stability of the oleosomes was similar as observed by Chen et al. 
(2004) and Choi and Chang (2009). 
 Particle Size.  Particle size among the different oil bodies were significantly  different 
from each other.  Oleosomes had the smallest diameter of particles and also had a wider 
range of particle size distribution (Figure 3).  Egg yolk protein had the next largest  average 
diameter followed by soy protein isolate.  Egg yolk protein size ranged from 0.1-10 µm and 
soy  protein isolate from 0.1-100 µm.  A study conducted by Chiou and Lai (2009) used 
caleosin, another protein found in oleosomes, to make AOB to encapsulate a photosensitizing 
drug.  They  were able to successfully encapsulate the drug and had smaller particle size, 122 
nm diameter.
 Microscope Images.  Figure 4 shows images taken from the beginning and the end of 
the experiment.  At the beginning of the experiment all samples had similar particle 
appearance but with some larger particles in the AOB samples.  This observation is 
confirmed with the particle size analysis.  Images taken at the end of the experiment revealed 
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significant changes over 30 days.  Oleosomes appear to maintain the numbers and also 
maintained a similar size to that at the beginning of the experiment.  Egg yolk protein oil 
bodies appear to have significantly lost in numbers with the few remaining appearing to have 
a similar size to the oleosomes with some oil bodies with larger diameters.  SPI oil bodies 
appeared to be mostly free oil.  Peng et al. (2003) studied the effect of temperature on sesame 
oleosomes and they were thermostable up to 60 °C.  The same conclusion was made with 
AOBs made of caleosin, decomposing at temperatures higher than 70 °C (Liu et al., 2009). 
Therefore our oxidation temperature of 55 °C should not be a significant factor in oleosome 
or AOB breakage.  However, the ability of the protein used to form AOB is the main factor.
 Oxidative Stability of the Encapsulated Soybean Oil.  Primary  oxidation of soybean 
oil is shown in Figure 5.  Oleosomes exhibited very little increase if any  in lipid oxidation. 
The soy oil started to increase in peroxide value towards the last 15 days.  The oil is a crude 
unrefined oil having the natural antioxidants, so it  is relatively stable, particularly  when oil is 
dispersed in water as an emulsion, its oxidation can be accelerated by many factors, such as 
large surface area and pro-oxidants in water.  Egg yolk protein AOB had an increased 
peroxide value and it peaked at day  28.  Soy  protein isolate AOB’s PV increased at a much 
faster rate and peaked at day 26.  Day 26 was used for statistical analysis where all treatments 
were significantly  different from each other with p-value of 0.0002.  This result suggests that 
neither yolk protein nor soy protein successfully created AOB when compare to the natural 
oleosome.  However, yolk protein may have performed better than soy protein.  Secondary 
oxidation had a results similar to primary oxidation.  Oleosomes and soy oil had a slow 
increase over the 30 days.  Egg yolk protein treatment had a lower TBARS than SPI 
treatment.  Day  26 was used for statistical analysis with all the treatments significantly 
different from each other with a p-value of 0.0001.
Effect of AOB Protein and Environment on Fish Oil Oxidation  
 At the start of the experiment, all samples appeared the same, creamy fully-dispersed 
systems with no visual free fish oil.  There were some interesting observations: egg yolk 
protein with 0 ppm CuSO4 at  pH 7 had no phase separation unlike egg yolk protein with 0 
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ppm CuSO4 at pH 3 which had a clear water and cream layer separation.  Egg yolk protein 
with 50 ppm CuSO4 at  pH 7 had two distinct cream layers whereas the egg yolk protein with 
50 ppm CuSO4 at pH 3 had a clear water and cream layer separation but not to the same 
degree as the egg yolk protein treatment of 0 ppm CuSO4 at pH 7 or 3. Oleosin with 0 ppm 
CuSO4 at pH 7 and 3 and 50 ppm CuSO4 at pH 7 had two distinct cream layers. The oleosin 
with 0 ppm CuSO4 at pH 3 had a clear water and cream layer separation.  By the end of the 
2-week experiment, the samples had greatly changed.  All the samples had visible oil and 
phase separation.  Samples with the 50 ppm CuSO4 have a darker color oil than the samples 
with 0 ppm CuSO4.  A study by Choi and Chang (2009) examined the effects of pH with 
AOB formed with oleosin and concluded that the negatively charged AOB possess 
electronegative repulsion at pH 7, but tend to aggregate when the surface negative charges 
were neutralized at pH lower than 6.  Therefore the aggregate samples with pH 3 can be 
explained by this charge neutralization fact.
 Turbidity Test. Figure 7 shows the stability of AOB created with the oleosin and egg 
yolk protein.  For yolk protein AOB, the pH environment and CuSO4 addition did not affect 
the initial stability  of the emulsion.  However, for oleosin AOB, the particles were very 
unstable at pH 3 compared to at  pH 7 and the CuSO4 addition seemed to have slightly 
reduced the stability.  Peng et  al. (2007) used recombinant oleosin expressed by E. coli. using 
the same ratio of protein, phospholipid, and oil as this present study  and observed the AOB 
made with the oleosin was comparable to the turbidity  exhibited by the sesame seed 
oleosomes.  Another study by Chen et al. (2004) showed a larger decrease in stability  from 
their turbidity test over three hours using oleosin, under similar conditions at pH 7.5 with 
stability  reduced to 85%.  This study’s oleosin at pH 7 only  decreased to approximately  92% 
relative turbidity.  
 Particle Size Distribution.  Particle size measurement is presented in Table 1. 
Oleosin 0 ppm CuSO4 pH 3 had the largest diameter size particle and egg yolk protein 0 ppm 
CuSO4 pH 7 had the smallest.  All the samples had a narrow peak similar to the peaks of 
natural soy  oleosomes.  As shown in Table 1 the particle size for all treatments are bigger at 
pH 3 than at  pH 7.  Egg yolk AOB are smaller particles than oleosin.  Therefore, egg yolk 
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protein seemed to have outperformed oleosin for creating physically stable AOB. 
Kiosseoglou (2003) observed a similar trend where yolk emulsion (10% corn oil and 1% 
yolk) had a larger particle size at pH 3.8 than compared to pH 7.  Magnusson and Nilsson 
(2011) also had similar results when they compared egg yolk livetin emulsions at pH 4.0, 4.5, 
6.0, and 8.0 had smaller particle sizes observed at pH 6.0 and 8.0 than compared to pH 4.0 
and 4.5.  
 Microscopic Images. Images of the samples were taken at the beginning and the end 
of the 2-week time span.  The beginning images can be seen in Figure 8.  These observations 
in general correlate with the particle size measurement at the beginning of the experiment. 
By the end of the 2 weeks all samples had drastically changed because not many oil bodies 
can be found in the samples.  Egg yolk protein and oleosin with 0 ppm CuSO4 at pH 7 
appeared still stable at  day 7 of the experiment under the light  microscope.  Magnusson and 
Nilsson (2011) observed very  similar results to our own at day  7 of the experiment by using 
egg livetin for emulsion formation.  
 Oxidative Stability of Fish Oil Encapsulated in AOB Created by Egg Yolk Protein 
and Oleosin. The peroxide value and TBARS were completed for only  the first nine days of 
the study due to the lack of any trend and the breakage of the emulsions.  Peroxide value 
changes are shown in Figure 9.  The only sample that exhibited a typical peroxide value trend 
was the fish oil control. The variation of peroxide values can be attributed to the 
homogeneity  of the oxidized free oil when the samples were taken from the broken 
emulsions.    
 A similar trend can be seen for the TBARS values as seen in Figure 10. Fish oil 
sample displayed the typical pattern for TBARS, since a gradual increasing line of TBARS 
was formed.  This oxidative stability trial is thus a failed experiment because the AOB was 
not very  stable and the release of free oil made the sampling for oxidation measurement 
impossible.
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Solubility Curve
 Oleosin protein  and egg yolk protein solubility curve is shown in Figure 11.  Oleosin 
has a very low solubility at pH <10.  There is no difference in solubility  shown where 
experiment was conducted at pH 3 and 7.  The egg yolk protein solubility was also similar at 
pH 3 and 7. Therefore, this curve alone cannot explain the charge effect  on emulsion stability 
due to pH change.
CONCLUSION
 In this study, fish oil and soybean oil were encapsulated by using egg yolk protein, a 
novel use for this protein. From the experiments shown, the environment and protein can 
have effects on the stability  of the AOB formed.  AOB constitution by egg yolk protein 
showed a great promise to encapsulate and protect oil from oxidation.  More research needs 
to be done to fully explore such potential.
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Table 1. Particle Size of AOB Created by Egg 
Yolk Protein and Oleosin
Sample1 Surface Weight 
Mean (µm) (n=4)
Egg Yolk Protein 0 ppm pH 7
Egg Yolk Protein 0 ppm pH 3
Egg Yolk Protein 50 ppm pH 7
Egg Yolk Protein 50 ppm pH 3
Oleosin 0 ppm pH 7
Oleosin 0 ppm pH 3
Oleosin 50 ppm pH 7
Oleosin 50 ppm pH 3
P-value
1.069 ± 0.115 d
6.101 ± 1.960 b
1.367 ± 0.061 cd
2.048 ± 0.113 cd
2.365 ± 0.259 c
27.456 ± 1.169 a
2.162 ± 0.275 cd
5.155 ± 1.026 b
**
1ppm concentration are of CuSO4.
Values are mean ± standard deviations.
** P-value ≤ 0.0001
123
Figure 1. Defatting of egg protein by using hexanes for each of the fractions collected.  
Values are shown with standard deviations.
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Figure 2.  Stability  of naturally occurring soy oleosomes, AOB made with egg yolk 
protein, and SPI.  There was no significant difference among the samples. Chart has mean 
and standard deviation bars.
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Figure 3. Particle size distribution of native soy oleosomes and AOB made with egg yolk 
protein and SPI at the start of the experiment.
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Figure 4. Microscopic images under 100x magnification.  Soy oleosomes day 0 (A), soy 
oleosomes day 30 (B), egg yolk protein day  0 (C), egg yolk protein day 30 (D), SPI day 0 
(E), and SPI day 30 (F).  The line represents 10 µm.
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Figure 5. Lipid hydroperoxide of soybean oil in naturally  occurring oleosomes and AOB 
made with egg yolk protein, and SPI over 30 days. Soybean bulk oil was used a control. 
Standard deviation bars are shown.
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Figure 6. Secondary oxidation analysis by 2-thiobarbituric acid-reactive substances 
(TBARS) for of soybean oil in naturally occurring oleosomes and AOB made with egg yolk 
protein, and SPI over 30 days. Standard deviation bars are shown.
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Figure 7. Stability of AOB made with egg yolk protein and oleosin with varying treatments 
of pH 7 or 3, and 0 or 50 ppm CuSO4. All charts have mean and standard deviation bars.
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Figure 8. Microscopic images under 100x magnification. Egg yolk protein (EYP) 0 ppm 
CuSO4, pH 7 (A); EYP 0 ppm CuSO4, pH 3 (B); EYP 50 ppm CuSO4, pH 7 (C); EYP 50 
ppm CuSO4, pH 3 (D); oleosin 0 ppm CuSO4, pH 7 (E); oleosin 0 ppm CuSO4, pH 3 (F); 
oleosin 50 ppm CuSO4, pH 7 (G); and oleosin 50 ppm CuSO4, pH 3 (H) at the experiment 
beginning.  The line represents 10 µm.
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Figure 9. Primary oxidation analysis for peroxide value comparing egg yolk protein (EYP) 0 
ppm CuSO4, pH 7; EYP 0 ppm pH 3; EYP 50 ppm pH 7; EYP 50 ppm pH 3; oleosin 0 ppm, 
pH 7; oleosin 0 ppm pH 3; oleosin 50 ppm pH 7; and oleosin 50 ppm pH 3 over 2 weeks. All 
charts have mean and standard deviation bars.
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Figure 10. Secondary oxidation analysis by  2-thiobarbituric acid-reactive substances 
(TBARS) for experiment 2: comparing egg yolk protein (EYP) 0 ppm CuSO4, pH 7; EYP 0 
ppm CuSO4, pH 3; EYP 50 ppm CuSO4, pH 7; EYP 50 ppm CuSO4, pH 3; oleosin 0 ppm 
CuSO4, pH 7; oleosin 0 ppm CuSO4, pH 3; oleosin 50 ppm CuSO4, pH 7; and oleosin 50 
ppm CuSO4, pH 3 over 2 weeks. All charts have mean and standard deviation bars.
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Figure 11. Oleosin (A) and egg yolk protein (B) solubility curves extracted by hexanes. 
Charts has mean and standard deviation bars.
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CHAPTER 6. GENERAL CONCLUSIONS
 The proteins in egg yolk typically are hydrophilic, but also contain hydrophobic 
groups that can be absorbed into oil-water interface.  Therefore this property  was exploited 
for artificial oil body formation.  In this study, soybean oil was successfully encapsulated by 
using egg yolk protein, a novel use for this protein. From the experiments shown, the 
environment and protein can have significant effects on the stability of the AOB formed. 
Egg yolk protein did create a better AOB than soy protein isolate.  The experiment with fish 
oil stabilization using the different proteins and environments was able to clearly  illustrate 
the effect pH and presence of an oxidizer has on the system. The samples with a pH of 3 
were less stable than the samples at pH 7.  AOB constitution by  egg yolk protein may  be a 
suitable technique to encapsulate oil that is easily oxidized therefore allowing the healthy oil 
to be consumed. 
 The feeding study with astaxanthin and vitamin E was able to illustrate the success of 
astaxanthin incorporation at higher concentrations than previously  seen in other studies 
where color enhancement was the goal.  This study shows astaxanthin and tocopherols can be 
successfully  incorporated into the egg yolk by adding the ingredients into the feed.  The 
higher the concentration in the feed the higher the concentration in the resulting egg yolk, 
however with lower transfer efficiency.  The reason could be that in the palm toco 
concentrate contained negligible amounts of β-, δ-, and γ-tocopherols (a total of 3 mg/g, 
0.6% of total tocos).  However, the feed itself had its own natural tocopherols from the 
natural ingredients. Because tocotrienols are not typically found in the natural ingredients in 
feeds, their feed enrichment led to a steady enrichment in eggs, and in a dose-response 
relationship.  There seems to be a feedback or competitive inhibition for all the nutrients. 
Despite the lack of tocotrienol transfer, this study  was able to illustrate there was no 
signifiant changes with the egg weight, texture properties, fatty acid composition, and 
phospholipids.  Changes in yolk color was related to the amount of astaxanthin in the diet. 
Changes in the yolk color will need to be examined for consumer acceptance.
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 Overall both studies illustrated the novel use of egg proteins and ways to manipulate 
the egg nutrient content by  changing the feed composition, thus confirming both of our 
original hypotheses. 
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APPENDIX
Table 1. Visual Progression of Color Change Throughout the Feeding Study
Diet
Fresh Yolk
Cooked 
Yolk
Day 0 Day 3 Day 6 Day 9 Day 42 Day 40
A
B
C
D
Diets are A no supplements, B enriched with 0.012% tocomin and 0.49% algae biomass; C 
enriched with 0.036% tocomin and 1.47% algae biomass; and D enriched with 0.072% 
tocomin and 2.94% algae biomass.
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Figure 1.  Setup of the chicken housing arrangements.  The water trays are in the middle of 
the rack and the feed is on the outside so there was no mixing of feeding diets.  Eggs were 
collected below the feed and drinking containers.
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   C 
 
 
   B 
 
  A
Figure 2. Image of chicken combs from each of the four different diets during week 7 
illustrating the coloration changes.  Chickens are labeled above with their respective diet 
starting on the left with Diet D and the right Diet A. Diets are A no supplements, B enriched 
with 0.012% tocomin and 0.49% algae biomass; C enriched with 0.036% tocomin and 1.47% 
algae biomass; and D enriched with 0.072% tocomin and 2.94% algae biomass.
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A B 
C D 
Figure 3. Images are of chicken feed from the end of the study  during week 7 illustrating the 
coloration changes.  Upper left is Diet A (no supplements), upper right Diet B (0.012% 
tocomin and 0.49% algae biomass), lower left Diet C (0.036% tocomin and 1.47% algae 
biomass), and lower right Diet D (0.072% tocomin and 2.94% algae biomass).  
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A B 
C D 
Figure 4. Images are of fecal matter from the chickens at the end of the study during week 7 
illustrating the coloration changes.  Upper left is diet  A (no supplements), upper right Diet B 
(0.012% tocomin and 0.49% algae biomass), lower left Diet C (0.036% tocomin and 1.47% 
algae biomass), and lower right Diet D (0.072% tocomin and 2.94% algae biomass).  
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A C
B D
FIGURE 5. Image of hard boiled eggs used for sensory panel testing.  Upper left is diet A, 
lower left diet B, upper right diet C, and lower right diet D.  Diets are A no supplements, B 
enriched with 0.012% tocomin and 0.49% algae biomass; C enriched with 0.036% tocomin 
and 1.47% algae biomass; and D enriched with 0.072% tocomin and 2.94% algae biomass.
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16:0
16:1
18:1
18:2
18:0
Figure 6. Typical gas chromatography chromatogram from the fatty  acid methyl ester 
analysis of day 10 egg oil samples.
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Figure 7. Liquid chromatography-mass spectra for Diet D egg sample after stabilization has 
occurred during the feeding study.  Top three images are of the absorbance at 450 nm (same 
wavelength as the HPLC analysis), mass spectra, and the mass spectra selected for 
astaxanthin’s molecular weight of 596.  The five peaks are identified and their respective 
scans of each are shown with astaxanthin identified.
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Absorbance at 450 nm
Mass Spectra
MS selected for ASTA
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Figure 7. (continued).
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